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Steffen N. Good: Development and Application of an Oxidative Dearomatization/Acylnitroso Diels–Alder 
Cycloaddition Cascade Toward the Total Synthesis of (±)-Tetrodotoxin 
(Under the direction of Jeffrey S. Johnson) 
I. Highly Functionalized Tricyclic Oxazinanones via Pairwise Oxidative Dearomatization and 
N-Hydroxycarbamate Dehydrogenation: Molecular Diversity Inspired by Tetrodotoxin. 
 
Benzenoids in principle represent attractive and abundant starting materials for the preparation of 
substituted cyclohexanes; however, the synthetic tools available for overcoming the considerable aromatic 
energies inherent to these building blocks limit the available product types. Drawing inspiration from the 
complex natural product tetrodotoxin, we demonstrate access to heretofore unknown heterotricyclic 
structures by leveraging oxidative dearomatization of 2-hydroxymethyl phenols with concurrent N-
hydroxycarbamate dehydrogenation using a common oxidant. The pairwise-generated, mutually reactive 
species then participate in a second stage acylnitroso DielsAlder cycloaddition.  The reaction chemistry of 
the derived [2.2.2]-oxazabicycles, bearing four orthogonal functional groups and three stereogenic centers, 
is shown to yield considerable diversity in downstream products. 
 
II. Oxidative Dearomatization/Acylnitroso Diels–Alder Cycloaddition Cascade:  An Approach 
Toward the Total Synthesis of (±)-Tetrodotoxin 
 
Tetrodamine, a common conceptual intermediate en route to tetrodotoxin, represents a challenging 
synthetic target due to its densely functionalized cyclohexane core.  Capitalizing on the latent functionality 
embedded within the benzenoid nucleus, we deploy an oxidative dearomatization/acylnitroso Diels–Alder 
 
iv 
cycloaddition cascade to access a highly functionalized cyclohexanone intermediate bearing structural and 
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1Chapter One: Highly Functionalized Tricyclic Oxazinanones via Pairwise Oxidative 




 The latent functionality embedded within the benzene nucleus offers tantalizing opportunities to 
chemists seeking to deploy the parent aromatic core structure as a point of departure for synthesizing chiral, 
functionalized cyclohexanes.  The key challenge thwarting the realization of this potential is the design not 
only of transformations that overcome the formidable aromatic stabilization energy associated with 
benzenoids,1-7 but also a suitable second stage reaction that takes advantage of the functionality, often of 
tenuous stability, revealed in the first stage.  The work described here uses the cyclohexane substructure 
of the complex natural product tetrodotoxin (TTX, 1.1, Scheme 1-1) as an inspiration to develop a new 
oxidative dearomatization cascade sequence for the de novo creation of heterotricyclic compounds 
presenting four orthogonal functional groups.  We demonstrate that considerable product diversity is 
available from this new platform. 
1.2. Background 
1.2.1  History and Retrosynthetic Analysis of Tetrodotoxin 
 Tetrodotoxin (1.1), a potent neurotoxin first isolated from puffer fish, has garnered significant 
attention since its structure was first elucidated in 1964 due to its unique biological properties and densely 
functionalized structure (Scheme 1-1).8  (−)-TTX inhibits voltage gated sodium ion channels and is 
consequently a leading molecular probe for further study in this area.9  Additionally, (−)-TTX has been under 
study as a treatment for chemotherapy-induced neuropathic pain.10  Since the first synthesis of (±)-TTX by 
Kishi in 1972, there have been five total syntheses, each enabled by the development of creative tactics to 
access the densely functionalized core.11-19  While the recent chemoenzymatic formal synthesis of (–)-TTX 
                                                     
*Reprinted in part with permission from Good, S. N.; Sharpe, R. J.; Johnson, J. S. J. Am. Chem. Soc. 




by Hudlicky required only 22 steps,20 the synthesis of TTX remains challenging; all previous syntheses 
require >30 steps.  “Tetrodamine” (1.2, Scheme 1-1) is a common conceptual target in 
Scheme 1-1.  Synthetic Strategy for Tetrodotoxin and Proposed Pairwise Oxidation/Cycloaddition 
 
tetrodotoxin syntheses.11-18  The C6–C7–C8–C8a stereotetrad comprises a challenging functional group 
constellation. The C7/C8 syn-diol is suggestive of a cis alkene difunctionalization; direct dihydroxylation of 
a suitably substituted benzene has been suggested as a potential entry point for tetrodotoxin20 and OsO4-
catalyzed alkene functionalization was realized en route to 1.2.18  Perhaps more nettlesome is the 
C6/C8a syn-1,4-aminocyclohexanol where both heteroatoms reside at fully substituted stereogenic  






centers (Scheme 1-1).  As such, the challenging installation of nitrogen at C8a has inspired a number of 
creative approaches typically utilizing intramolecular strategies (Scheme 1-2).11-14,16,18  In considering 
retrosynthetic approaches, the presence of a C7/C8 alkene and antithetic reconnection of the C6/C8a 
amino alcohol (Scheme 1-1, red arrows) would create a retron for an acylnitroso Diels–Alder 
cycloaddition.21 We envisioned oxidative remodeling of an achiral benzenoid could be triggered by Adler 
oxidation of the corresponding salicyl alcohol 1.4.22 Trapping the resulting spiroepoxydienone 1.6 with a 
concurrently generated dienophile 1.5 might trigger a second stage hetero-Diels–Alder cycloaddition 
(Scheme 1-3). An enabling feature of the envisioned strategy is that acylnitroso 1.5 and 
epoxydienone 1.6 could in principle be prepared by oxidation of N-hydroxycarbamate 1.323 and salicyl 
alcohol 1.4, respectively, with a common oxidant.24  Development of this methodology would allow for the  
Scheme 1-3. Proposed Pairwise Oxidation/Cycloaddition Cascade 
 
rapid preparation of rigid, bicyclic products with four orthogonal functional groups from simple, aromatic 
feedstock while potentially allowing for an expeditious, flexible synthesis of the tetrodamine substructure 
and ultimately (±)-TTX and its structural congeners.25 
1.3 Results and Discussion 
1.3.1 Acylnitroso Diels–Alder Cycloaddition Optimization 
 We began by investigating the proposed acylnitroso Diels–Alder cycloaddition (Table 1-1).  The 
known dimerization of spiroepoxydienones was a concern;26 therefore, spiroepoxydienone 1.7, a compound 




bears an analogous substitution pattern to an idealized substrate for elaboration to TTX.  Treating 
spiroepoxydienone 1.7 with N-hydroxycarbamate 1.8 under Cu(II)-catalyzed aerobic oxidation conditions28 
afforded a 1.5:1 mixture of the desired Diels–Alder cycloadduct 1.9 (5.4:1 dr) and salicyl alcohol 1.12 (Table 
1-1, entry 1).  Formation of alcohol 1.12 only occurred in the presence of 1.8, suggesting the in situ reduction 
of 1.7 could not be prevented under these reaction conditions.  Stoichiometric quantities of tetra-n-
butylammonium periodate (nBu4NIO4) in CH2Cl2 afforded cycloadduct 1.9 (2.3:1 dr) in low conversion 
without any observable formation of 1.12 (entry 2).  Repeating the reaction in CDCl3 at 45 °C showed trace 
conversion to 1.9, but full consumption of 1.8 after 1 h.  Based on these observations, we speculated that 
decomposition of the transient acylnitroso species, which has a lifetime on the order of 1 ms at infinite 
dilution,23 was likely the source of the poor reactivity. Accordingly, we proposed the reactivity could be 
enhanced by maintaining an excess of spiroepoxydienone 1.7 relative to the acylnitroso species; therefore, 
an additional 2 equiv of nBu4NIO4 were added followed by the dropwise addition of 1.8 (2 equiv) over 2 h, 
affording cycloadduct 1.9 (3.2:1 dr) in 57% conversion 
Table 1-1.  Optimization of the Acylnitroso Diels–Alder Cycloaddition  
 
(entry 3).  When the reaction was conducted in CHCl3 (entry 5), phenol 1.12 was observed in similar 
quantities relative to the Cu(II)-catalyzed aerobic oxidation conditions (entry 1).  The variance in reactivities 




by ethanol, typically present in CHCl3 as a stabilizer.  Indeed, a similar effect was observed when methanol 
was used as the solvent (entry 1).  In light of these observations, we avoided these and similar reaction 
media in subsequent experiments.  Further optimization showed increased conversion of 
1.7 using Cbz analog 1.10, but cycloadduct 1.11 was isolated in only 12% yield (entries 5, 6).  Repeating 
the reaction at cooler temperatures resulted in increased conversions and isolated yields of 1.11 (entries 
7, 8).  The diminished yields at elevated temperatures indicated possible thermal instability of the 
cycloadducts.  Specifically, retro Diels–Alder cycloaddition followed by incomplete recombination and 
decomposition of the acylnitroso species was hypothesized.  This hypothesis was later confirmed via a 
crossover experiment (vide infra).  
1.3.2 Development of a One-pot Oxidation/Acylnitroso Diels–Alder Cycloaddition 
 To explore the viability of a one-pot Adler oxidation/acylnitroso cycloaddition sequence, we added 
a solution of 1.10 over 2 h to a mixture of salicyl alcohol 1.13 and NaIO4 in methanol/water (Table 1-2, entry 
1).  Full conversion of phenol 1.13 to spiroepoxydienone 1.15 was observed after 15 min, but complete 
reduction of 1.15 back to 1.13 was observed after 1 h.  Screening nBu4NIO4 as the oxidant and  
Table 1-2. Optimization of the One-pot Adler Oxidation/Acylnitroso Cycloaddition Protocol 
 
removing methanol as a solvent returned identical results (entries 2-4).  Excluding water from the reaction 
afforded cycloadduct 1.14 (>20:1 dr), albeit in low conversion (entry 5).  These results indicated that excess 
water was promoting the Adler oxidation while simultaneously promoting the reduction of intermediate 
spiroepoxydienone in the presence of the acylnitroso species in water-miscible solvents.  Collectively, these 




(entry 6, 7).  Indeed, using CH2Cl2 as the co-solvent afforded 1.14 in excellent yield with complete 
consumption of 1.13 (entry 7). 
1.3.3 Substrate Scope and Dienophile Facial Selectivity 
 We next probed the scope of the corresponding one-pot procedure (Table 1-3).  Readily available 
electron-rich and electron-poor salicyl alcohols29-31 were tolerated, affording the derived cycloadducts in 
good yield.  For most substrates, the cycloadduct is initially formed with >20:1 dr; however, cycloadducts 
1.11 and 1.19 were isolated as a mixture of equilibrating diastereomers (determined by chemical 
derivatization and selective 1D NOESY NMR analysis; see experimental details (Section 1.4) for details). 
Table 1-3. Scope of the One-Pot Oxidative Dearomatization/Acylnitroso Cycloaddition Cascade 
 
An X-ray diffraction study of bicyclic dihydrooxazine 1.9 (Table 1-1) revealed a regiochemical preference 
for the illustrated isomer, which matched that needed for extrapolation to TTX,27 and acylnitroso approach 
from the methylene face of the epoxide of 1.7.  The observed facial selectivity was surprising as C–C 
dienophile approach from the oxygen face of spiroepoxydienones is well documented.26  By contrast, an X-
ray diffraction study of dihydrooxazine 1.14 revealed acylnitroso approach from the oxygen face of the 
epoxide.  We hypothesize that acylnitroso approach from the oxygen face of the epoxide is kinetically 
favored while the “methylene endo” product is the more thermodynamically stable diastereomer.  This 
hypothesis is additionally supported by the diminished pre-equilibration diastereoselectivities observed for 
cycloadducts 1.11 and 1.19 (see section 1.5 for experimental details), the slow isomerization of cycloadduct 




experiment between 1.19 and Boc–NO confirmed a retro-Diels–Alder/recombination sequence, providing 
a likely pathway for isomerization of the dihydroxazine cycloadducts (see section 1.5 for experimental 
details of the crossover experiment and thermal isomerization).  
1.3.4 Secondary Transformations of the [2.2.2]-cycloadducts 
 The reactivity of cycloadduct 1.16 was explored in a number of orthogonal transformations that 
independently probed each functional group (Scheme 1-4).  Reduction of the ketone afforded alcohol 1.24 
in good yield while ring-opening of the epoxide was achieved by treating ketone 1.16 with 
bromodimethylsulfonium bromide,32 yielding bromohydrin 1.25.  Gram-scale dihydroxylation of 1.16 gave 
Scheme 1-4.  Chemoselective Reactions of Heterocycloadducts 
 
diol 1.26 with high diastereoselection and matched stereochemistry needed for elaboration toward 
tetrodamine 1.2.  Subsequent one-pot oxazinane reduction33 and epoxide ring-opening34 afforded 




yield.35  Reductive fragmentation36 of epoxyoxime 1.29 afforded primary alcohol 1.30 and thence the 
crystalline bis-(p-nitrobenzoate) 1.31.  Corey-Chaykovsky epoxidation37 afforded bis-epoxide 1.32. 
1.4 Conclusions 
 In summary, we developed a one-pot oxidative dearomatization/acylnitroso Diels-Alder 
cycloaddition cascade sequence for the rapid preparation of rigid [2.2.2]-bicyclic products bearing four 
orthogonal functional groups from simple, aromatic feedstocks.  The synthetic utility of these new 
cycloadducts was demonstrated through an array of chemoselective transformations.   
1.5 Experimental Details 
Methods 
General:  Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier transform infrared 
spectrometer. Proton and carbon magnetic resonance spectra (1H NMR and 13C NMR) were recorded on 
a Bruker model Avance 400 (1H NMR at 400 MHz), Bruker Avance III 500 (1H NMR at 500 MHz and 13C 
NMR at 126 MHz), or a Bruker Avance III 600 (1H NMR at 600 MHz and 13C NMR at 151 MHz) spectrometer 
with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.26 ppm, (CD3)2CO at 2.05 ppm, 
CD3OD at 3.31 ppm; 13C NMR: CDCl3 at 77.0 ppm, CD2Cl2 at 53.5 ppm, (CD3)2CO at 206 ppm, CD3OD at 
49 ppm). 1H NMR data are reported as follows: chemical shift, multiplicity (s = singlet, br s = broad singlet, 
d = doublet, t = triplet, q = quartet, hept = heptet, dd = doublet of doublets, ddd = doublet of doublet of 
doublets, dq = doublet of quartets, m = multiplet), coupling constants (Hz), and integration. Mass spectra 
were obtained using a Thermo LTqFT mass spectrometer with electrospray introduction and external 
calibration unless otherwise noted. All samples were prepared in methanol. Analytical thin layer 
chromatography (TLC) was performed on Sorbent Technologies 250 µm glass-backed Silica Gel TLC 
plates. Visualization was accomplished with UV light, KMnO4, ceric ammonium molybdate (CAM), and/or 
Seebach’s stain followed by heating. Purification of the reaction products was carried out by flash 
chromatography using Siliaflash-P60 silica gel (40-63μm) purchased from Silicycle. Unless otherwise 
noted, all reactions were carried out under an atmosphere of dry nitrogen with magnetic stirring. Yield refers 
to isolated yield of analytically pure material unless otherwise noted. Yields are reported for a specific 
experiment and as a result may differ slightly from those found in figures, which are averages of at least 





General:  Solvents were not dried prior to use unless specified as “anhydrous.” Anhydrous tetrahydrofuran 
(THF), diethyl ether (Et2O), and dichloromethane (CH2Cl2) were dried by passage through a column of 
neutral alumina under nitrogen prior to use.  Anhydrous dimethylformamide (DMF) was purchased from 
Sigma-Aldrich and was used as received.  Ethyl acetate (EtOAc) was purchased from Fisher Scientific and 
was used as received.   
Experimental Procedures: 
 
5,8-Dimethyl-1-oxaspiro[2.5]octa-5,7-dien-4-one (1.7): A solution of NaIO4 (773 mg, 3.61 mmol) in water 
(5 mL) was added to a solution of 2-hydroxy-3,5-dimethylbenzyl alcohol31 (500 mg, 3.29 mmol)  in MeOH 
(20 mL) at rt.  The mixture was stirred for 1 h at rt, resulting in the formation of a precipitate.  The reaction 
was diluted with water (40 mL) and the aqueous layer was extracted with diethyl ether (3 × 40 mL).  The 
combined extracts were washed with brine (60 ml), dried over Na2SO4, filtered, and concentrated via rotary 
evaporation.  The crude material as purified via flash chromatography on silica gel (EtOAc:hexanes 20:80) 
to afford 1.7 as a yellow oil (401 mg, 81%).  Analytical data for 1.7: 1H NMR (400 MHz, CDCl3) δ 6.92 (d, J 
= 6.3 Hz, 1H), 6.24 (d, J = 6.3, 1, 1H), 3.22 (d, J = 8.3 Hz, 1H), 3.16 (d, J = 8.3 Hz, 1H), 1.90 (s, 3H), 1.80 
(s, 3H); 13C NMR (151 MHz, CDCl3) δ 196.4, 144.7, 138.9, 131.7, 123.8, 58.7, 58.7, 16.1, 15.1; IR (thin 
film, cm-1) 2980, 2948, 2921, 1662, 1640;  TLC (EtOAc:hexanes 20:80): Rf = 0.41; HRMS (ESI+):  Calcd. 
for C9H11O2: ([M+H]): 151.0759, Found: 151.0756. 
 
 
5-Isopropyl-8-methyl-1-oxaspiro[2.5]octa-5,7-dien-4-one (1.33):  NaIO4 (39 mg, 0.18 mmol) was added 
to a solution of 2-hydroxy-3-isopropyl-6-methylbenzyl alcohol30 (20 mg, 0.11 mmol) in MeOH/H2O (1:1, 2 
mL).  The reaction was stirred at rt under air for 1 h then diluted with water (3 mL).  The aqueous layer was 
extracted with diethyl ether (3 × 3 mL) and the combined extracts were washed with brine, dried over 




chromatography on silica gel (EtOAc:hexanes 10:90 to 20: 80) to afford 1.33 as a yellow oil (20 mg, 67 %).  
Analytical data for 1.33: 1H NMR(400 MHz, CDCl3) δ 6.86 (d, J = 6.5 Hz, 1H), 6.28 (dq, J = 6.5, 1.5 Hz, 1H), 
3.20 (d, J = 8.2 Hz, 1H), 3.13 (d, J = 8.2 Hz, 1H), 2.91 (hept, J = 6.9 Hz, 1H), 1.79 (d, J = 1.5 Hz, 3H), 1.07 
(d, J = 2.7 Hz, 3H), 1.06 (d, J = 2.7 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 195.3, 144.3, 141.6, 135.5, 
123.9, 59.0, 58.6, 26.1, 21.8, 21.6, 16.1; IR (thin film, cm-1) 2961, 2872, 1662, 1641, 1581;  TLC 
(EtOAc:hexanes 20:80): Rf = 0.45; HRMS (ESI+):  Calcd. for C11H15O2: ([M+H]): 179.1072, Found: 
179.1065. 
Preparation of [2.2.2]-Bicyclic Products: 
General Procedure A: 
 
A solution of NaIO4 (663 mg, 3.10 mmol) in water (10 mL) was added to a mixture of the salicyl alcohol 
(1.00 mmol) and N-benzyl-N,N,N-triethylammonium chloride (23 mg,  0.10 mmol) in CH2Cl2  (7.5 mL) at 0 
°C while stirring vigorously.  After 15 min, a solution of BnO2CNHOH (2.00 mmol) in CH2Cl2 (5 mL) was 
added over 2 h via syringe pump, maintaining the reaction temperature between 0-5 °C.  After complete 
addition, the reaction was stirred for 10 min.  The phases were partitioned and the aqueous phase was 
extracted with CH2Cl2 (2 × 10 mL).  The combined extracts were washed with brine (15 mL), dried over 
Na2SO4, filtered, and concentrated by rotary evaporation (the rotary evaporation water bath was maintained 
at ≤ 30 °C).  The crude product was purified via flash chromatography on silica gel.  All cycloadducts were 
stored at -20 °C.   
Note:  The acylnitroso Diels–Alder cycloadducts are generally not thermally stable above 30 °C due to 
appreciable retro-Diels–Alder and subsequent decomposition of the acylnitroso species and isomerization 
of the spiroepoxydienones to the corresponding salicyl aldehydes.  For this reason, the melting points of 
crystalline adducts are not reported. 
 
Benzyl 1,4-dimethyl-3-oxo-5-oxa-6-azaspiro[bicyclo[2.2.2]octane-2,2'-oxiran]-7-ene-6-




purified by flash chromatography on silica gel (EtOAc:hexanes 10:90 to 20:80)  to afford 1.11 as an 
equilibrating mixture of diastereomers as a yellow oil (1.5:1  dr determined by 1H NMR, 137 mg, 44%).  Note 
1:  the reported 1.5:1 dr refers to the ratio observed at the time the 1H NMR was taken and was calculated 
by comparison of the integration of the resonances at δ 6.72 (minor diastereomer) and δ 6.69 (major 
diastereomer).  An equilibrium (≈4:1 dr) is reached after a few hours at rt.  The equilibration can be slowed 
but not stopped upon storage at -20 °C (neat); however, the mixture of diastereomers is not thermally stable 
and will slowly degrade upon prolonged storage at -20 °C.  Note 2:  the title compound elutes slightly after 
benzyl alcohol (a byproduct from hydrolysis of the intermediate acylnitroso).  Separation of from benzyl 
alcohol can be achieved by holding the eluent at EtOAc:hexanes 15:85 until benzyl alcohol elutes.  Only 
definitively discernible peaks are reported in the 1H NMR spectra for each isomer.  Analytical data for 1.11:  
Major isomer, 1H NMR (600 MHz, CDCl3) δ 6.69 (d, J = 8.2 Hz, 1H), 6.21 (d, J = 8.2 Hz, 1H), 5.20 (d, J = 
12.3 Hz, 2H), 5.15 (d, J = 12.3 Hz, 1H), 3.12 (d, J = 5.7 Hz, 1H), 3.09 (d, J = 5.7 Hz, 1H), 1.67 (s, 3H), 1.64 
(s, 3H); Minor isomer, 1H NMR (600 MHz, CDCl3) δ 6.72 (d, J = 8.3 Hz, 1H), 6.21 (d, J = 8.3 Hz, 1H), 5.13 
(d, J = 12.4 Hz, 1H), 3.19 (d, J = 5.6 Hz, 1H), 3.05 (d, J = 5.6 Hz, 1H), 1.76 (s, 3H), 1.62 (s, 3H); Combined 
13C NMR (151 MHz, CDCl3) δ 196.6, 193.9, 160.0, 159.6, 144.0, 143.1, 135.5, 135.3, 130.1, 129.2, 128.6, 
128.6, 128.5, 128.4, 128.3, 127.9, 127.8, 82.6, 82.2, 68.3, 68.2, 65.3, 64.3, 58.7, 55.8, 55.4, 49.1, 48.9, 
15.9, 14.6; IR (thin film, cm-1) 2994, 2937, 1757, 1725, 1271, 1243; TLC  (EtOAc:hexanes 30:70): Rf = 0.30; 
HRMS (ESI+):  Calcd. for C17H18NO5: ([M+H]): 316.1185, Found: 316.1184. 
 
Benzyl 7-chloro-3-oxo-5-oxa-6-azaspiro[bicyclo[2.2.2]octane-2,2'-oxiran]-7-ene-6-
carboxylate (1.14): The title compound was prepared using General Procedure A and was 
purified by flash chromatography on silica gel (EtOAc:hexanes 20:80) to afford 1.14 as a yellow oil (246 
mg, 76%) which solidified upon storage.  The title compound was recrystallized by slow evaporation from 
MTBE/hexanes to afford crystals suitable for X-ray crystallographic analysis.   Analytical data for 1.14: 1H 
NMR (400 MHz, CDCl3) δ 7.38 (s, 5H), 6.54 (d, J = 6.5, 1H), 5.26 (d, J = 12.0 Hz, 1H), 5.21 (d, J = 12.0 Hz, 
1H), 5.05 (d, J = 6.5 Hz, 1H), 4.78 (s, 1H), 3.33 (d, J = 5.8 Hz, 1H), 3.16 (d, J = 5.8 Hz, 1H); 13C NMR (151 




film, cm-1) 3031, 1761, 1716, 1222; TLC  (EtOAc:hexanes 30:70): Rf = 0.29; HRMS (ESI+):  Calcd. for 
C15H12ClNNaO5: ([M+Na]): 344.0302, Found: 344.0294. 
 
Benzyl 3-oxo-5-oxa-6-azaspiro[bicyclo[2.2.2]octane-2,2'-oxiran]-7-ene-6-carboxylate 
(1.16): The title compound was prepared using General Procedure A and was purified by flash 
chromatography on silica gel (EtOAc:hexanes 20:80 to 40:60) to afford 1.16 as a yellow oil that slowly 
solidified upon storage to afford a white amorphous solid (202 mg, 70%).  Analytical data for 1.16: 1H NMR 
(400 MHz, CDCl3) δ 7.42 – 7.32 (m, 5H), 6.91 (ddd, J = 8.1, 6.0, 1.7 Hz, 1H), 6.66 (ddd, J = 8.1, 6.0, 2.2 
Hz, 1H), 5.25 (d, J = 12.1 Hz, 1H), 5.17 (d, J = 12.1 Hz, 1H), 4.97 (dd, J = 6.0, 1.7 Hz, 1H), 4.80 (dd, J = 
6.0, 2.2 Hz, 1H), 3.30 (d, J = 5.9 Hz, 1H), 3.01 (d, J = 5.9 Hz, 1H); 13C NMR (151 MHz, CDCl3) δ 194.4, 
158.4, 137.3, 134.9, 128.7, 128.6, 128.4, 128.2, 78.6, 68.9, 59.9, 53.5, 51.4; IR (thin film, cm-1) 3274, 1758, 
1716, 1220; TLC (EtOAc:hexanes 50:50, 2% v/v TEA/Et2O neutralized plate): Rf = 0.34; HRMS (ESI+):  
Calcd. for C15H13NNaO5: ([M+Na]): 310.0686, Found: 310.0692. 
 
Benzyl 7,8-dimethyl-3-oxo-5-oxa-6-azaspiro[bicyclo[2.2.2]octane-2,2'-oxiran]-7-ene-6-
carboxylate (1.17): The title compound was prepared using General Procedure A and was 
purified by flash chromatography on silica gel (EtOAc:hexanes 20:80) to afford 1.17 as a yellow 
oil (240 mg, 76%) which slowly crystallized upon storage.  Analytical data for 1.17: 1H NMR (400 MHz, 
CDCl3) δ 7.35 (m, 5H), 5.22 (d, J = 12.1 Hz, 1H), 5.17 (d, J = 12.1 Hz, 1H), 4.72 (s, 1H), 4.48 (s, 1H), 3.26 
(d, J = 5.7 Hz, 1H), 3.01 (d, J = 5.7 Hz, 1H), 1.88 (s, 3H), 1.86 (s, 3H); 13C NMR (151 MHz, CDCl3) δ 194.9, 
158.6, 140.2, 135.1, 128.7, 128.6, 128.6, 128.4, 83.4, 68.6, 64.4, 53.8, 50.5, 17.0, 15.1; IR (thin film, cm-1) 
3310, 1751, 1716, 1241, 1226; TLC  (EtOAc:hexanes 30:70): Rf = 0.34; HRMS (ESI+):  Calcd. for 
C17H18NO5: ([M+H]): 316.1185, Found: 316.1176. 
 
Benzyl 7-ethyl-3-oxo-5-oxa-6-azaspiro[bicyclo[2.2.2]octane-2,2'-oxiran]-7-ene-6-
carboxylate (1.18): The title compound was prepared using General Procedure A and was 
purified via flash chromatography on silica gel (EtOAc:hexanes 20:80) to afford 1.18 as a 




desired.  Analytical data for 1.18: 1H NMR (400 MHz, CDCl3) δ 7.36 (s, 5H), 6.17 (br s, 1H), 5.25 (d, J = 
12.1 Hz, 1H), 5.16 (d, J = 12.1 Hz, 1H), 4.95 (d, J = 6.2 Hz, 1H), 4.57 (s, 1H), 3.28 (d, J = 5.9 Hz, 1H), 3.00 
(d, J = 5.9 Hz, 1H), 2.52 – 1.93 (m, 2H), 1.03 (t, J = 7.3 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 194.4, 158.5, 
135.1, 128.7, 128.6, 128.5, 117.8, 117.7, 79.1, 68.7, 63.5, 53.6, 50.7, 27.6, 10.3; IR (thin film, cm-1) 2968, 
1757, 1716, 1224; TLC  (EtOAc:hexanes 30:70): Rf = 0.34; HRMS (ESI+):  Calcd. for C17H18NO5: ([M+H]): 
316.1185, Found: 316.1175. 
 
Benzyl 4-isopropyl-1-methyl-3-oxo-5-oxa-6-azaspiro[bicyclo[2.2.2]octane-2,2'-oxiran]-
7-ene-6-carboxylate (1.19): The title compound was prepared using General Procedure A 
and was purified by flash chromatography on silica gel (EtOAc:hexanes 10:90 to 15:85) to afford 1.19 as a 
mixture of equilibrating diastereomers (yellow oil, 3.4:1 dr determined by 1H NMR, 144 mg, 45%).  Note:  
the diastereomer ratio was determined by comparison of the integrations of the resonances at δ 6.81 (minor 
diastereomer) and δ 6.77 (major diastereomer).  Only distinguishable peaks are reported for each 
diastereomer in the 1H NMR spectra.  Analytical data for 1.19:  Major isomer, 1H NMR (500 MHz, CDCl3) δ 
6.77 (d, J = 8.4 Hz, 1H), 6.32 (d, J = 8.4 Hz, 1H), 5.17 (d, J = 12.0 Hz, 1H), 5.11 (d, J = 12.0 Hz, 1H), 3.07 
(d, J = 5.7 Hz, 1H), 3.04 (d, J = 5.7 Hz, 1H), 1.66 (s, 3H), 1.03 (d, J = 6.9 Hz, 3H); Minor isomer, 1H NMR 
(500 MHz, CDCl3) δ 6.81 (d, J = 8.5 Hz, 1H), 6.34 (d, J = 8.5 Hz, 1H), 5.16 (d, J = 12.1 Hz, 1H), 5.10 (d, J 
= 12.1 Hz, 1H), 3.13 (d, J = 5.7 Hz, 1H), 3.01 (d, J = 5.7 Hz, 1H), 1.76 (s, 3H), 1.01 (d, J = 6.9 Hz, 3H); 
combined 13C NMR (126 MHz, CDCl3) δ 196.0, 193.1, 160.0, 160.0, 144.8, 143.9, 135.2, 135.1, 128.4, 
128.4, 128.4, 128.3, 128.3, 128.3, 126.4, 126.2, 87.4, 87.1, 68.3, 68.3, 65.0, 63.9, 56.1, 55.6, 48.8, 48.7, 
27.2, 26.8, 17.1, 17.0, 16.6, 16.6, 15.9, 15.7; IR (thin film, cm-1) 3066, 3033, 2967, 2881 1755, 1724, 1268; 




carboxylate (1.20): The title compound was prepared using General Procedure A and was 
purified by flash chromatography on silica gel (EtOAc:hexanes 20:80 to 40:60) to afford 1.20 as a yellow 




= 8.9, 5.6 Hz, 1H), 6.51 (dd, J = 8.9, 1.9 Hz, 1H), 5.21 (s, 2H), 4.72 (dd, J = 5.7, 1.9 Hz, 1H), 3.73 (s, 3H), 
3.31 (d, J = 5.9 Hz, 1H), 3.02 (d, J = 5.9 Hz, 1H); 13C NMR (151 MHz, CDCl3) δ 191.14, 158.8, 137.2, 135.0, 
128.8, 128.6, 128.6, 128.3, 102.4, 68.8, 59.9, 53.9, 53.9, 51.2; IR (thin film, cm-1) 1770, 1716, 1259, 1220; 




carboxylate (1.21): The title compound was prepared using General Procedure A and was 
purified by flash chromatography on silica gel (EtOAc:hexanes 20:80 to 50:50) to afford 1.21 as a yellow 
oil (50 mg, 16%)  Analytical data for 1.21: 1H NMR (400 MHz, CDCl3) δ 7.43 – 7.31 (m, 5H), 5.28 (d, J = 
12.1 Hz, 1H), 5.21 – 5.12 (m, 2H), 5.07 (d, J = 7.0 Hz, 1H), 4.63 (d, J = 3.2 Hz, 1H), 3.60 (s, 3H), 3.30 (d, 
J = 5.9 Hz, 1H), 3.09 (d, J = 5.9 Hz, 1H); 13C NMR (151 MHz, CDCl3) δ 192.9, 163.0, 158.3, 135.2, 128.5, 
128.5, 128.5, 89.3, 79.7, 68.7, 62.9, 56.2, 53.7, 50.5; IR (thin film, cm-1) 3260, 1757, 1716, 1624, 1226; 




carboxylate (1.22): The title compound was prepared using General Procedure A and was 
purified by flash chromatography on silica gel (acetone:pentane 10:90 to 20:80) to afford 1.22 as a yellow 
foam (165 mg >20:1 dr, 45%).  Note 1:  The title compound isomerizes readily at rt (8.3:1 dr after 40 min in 
CDCl3).  The isomerization is slowed significantly if the title compound is stored neat at -20 °C (>20:1 dr 
after 8 months).  The diastereomer ratio was determined by comparison of the integration of the resonances 
at δ 4.86 (major diastereomer) and δ 4.69 (minor diastereomer).  Analytical data for 1.22: 1H NMR (500 
MHz, CDCl3) δ 7.61 – 7.54 (m, 2H), 7.49 – 7.39 (m, 3H), 7.38 – 7.31 (m, 5H), 7.02 (dd, J = 8.4, 5.9 Hz, 1H), 
6.66 (dd, J = 8.4, 2.1 Hz, 1H), 5.24 (d, J = 12.3 Hz, 1H), 5.20 (d, J = 12.3 Hz, 1H), 4.86 (dd, J = 5.9, 2.1 Hz, 
1H), 3.36 (d, J = 5.9 Hz, 1H), 3.07 (d, J = 5.9 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 193.5, 158.8, 135.2, 








ene-6-carboxylate (1.23): The title compound was prepared using General Procedure A and 
was purified by flash chromatography on silica gel (EtOAc:hexanes 15:85 to 40:60) to afford 1.23 as a 
yellow foam as a 2.3:1 mixture with the hydrate (265 mg, 66%).  Note 1:  the title compound streaks on the 
TLC plate.  If the plate is neutralized with a 2% TEA in Et2O solution the title compounds can be observed 
a tight spot (EtOAc:hexanes 50:50).  Note 2: the title compound is observed as a single product in the crude 
1H NMR but forms a hydrate during purification.  The hydrate could be stirred over 3Å molecular sieves in 
CH2Cl2 for 5-6 h to afford the title ketone as a single diastereomer.  Note 3:  the compound is not thermally 
stable and the spiroepoxydienone (from retro Diels–Alder) can be observed in the 1H and 13C NMR spectra 
after stirring the hydrate with molecular sieves.  Analytical data for 1.23: 1H NMR (500 MHz, CDCl3) δ 7.38 
(m, 5H), 6.60 (d, J = 2.8 Hz, 1H), 5.28 (d, J = 12.0 Hz, 1H), 5.25 (d, J = 12.0 Hz, 1H), 4.75 (d, J = 2.8 Hz, 
1H), 3.39 (d, J = 5.8 Hz, 1H), 3.21 (d, J = 5.8 Hz, 1H); 13C NMR (151 MHz, CDCl3) δ 185.6, 157.5, 138.8, 
134.5, 128.3, 128.7, 128.5, 127.2, 89.3, 69.6, 66.7, 52.4, 51.1; IR (thin film, cm-1); TLC  (EtOAc:hexanes 
50:50, TEA neutralized plate): Rf = 0.24; HRMS (ESI+):  Calcd. for C16H15BrClNaNO6: ([M+CH3OH+Na]): 




Benzyl 3-hydroxy-5-oxa-6-azaspiro[bicyclo[2.2.2]octane-2,2'-oxiran]-7-ene-6-carboxylate (1.24): 
NaBH4 (4.6 mg, 0.12 mmol) was added to a solution of 1.16 (100 mg, 0.35 mmol) in THF (3.3 mL) at 0 
°C.  After stirring at 0 °C for 1 h, the reaction was quenched with saturated NH4Cl (5 mL).  The aqueous 
layer was extracted with EtOAc (3 × 5 mL), and the combined extracts were washed with brine (10 mL), 
dried over Na2SO4, filtered, and concentrated by rotary evaporation.  The crude residue was purified via 




mixture of diastereomers as a colorless oil (71 mg, 71% combined, 1.7:1 dr determined by 1H NMR).  The 
diastereomer ratio was determined by comparison of the integration of the resonances at δ 4.88 (minor 
diastereomer) and δ 4.85 (major diastereomer).  Note:  only distinguishable peaks are reported for each 
diastereomer in the 1H NMR spectra.  Analytical data for 1.24: Major diastereomer, 1H NMR (600 MHz, 
CDCl3) δ 6.61 (t, J = 7.0 Hz, 1H), 5.20 (d, J = 12.2 Hz, 1H), 5.11 (d, J = 12.2 Hz, 1H), 4.85 (dt, J = 5.9, 1.7 
Hz, 1H), 3.67 (dd, J = 8.2, 1.7 Hz, 1H), 3.04 (d, J = 4.5 Hz, 1H), 2.90 (d, J = 4.5 Hz, 1H); Minor diastereomer, 
1H NMR (600 MHz, CDCl3) δ 6.70 (t, J = 7.0 Hz, 1H), 5.19 (d, J = 12.2 Hz, 1H), 5.10 (d, J = 12.2 Hz, 1H), 
4.88 (ddd, J = 5.9, 4.4, 1.8 Hz, 1H), 4.12 (dd, J = 7.0, 4.4 Hz, 1H), 3.12 (d, J = 4.7 Hz, 1H), 2.78 (d, J = 4.7 
Hz, 1H); Combined 13C NMR (151 MHz, CDCl3) δ 158.2, 158.1, 135.3, 135.2, 131.1, 130.4, , 128.5, 128.4, 
128.3, 128.2, 128.2, 77.2, 74.3, 68.6, 68.4, 68.3, 68.2, 67.9, 67.5, 65.2, 62.1, 58.4, 57.0, 55.3, 52.8, 49.1; 
IR (thin film, cm-1) 3447, 1704, 1733, 1327, 1263, 1232, 1100, 1059; TLC  (EtOAc:hexanes 60:40): Rf = 
0.21; HRMS (ESI+):  Calcd. for C15H16NO5: ([M+H]): 290.1029, Found: 290.1021. 
 
 
Benzyl 8-(bromomethyl)-8-hydroxy-7-oxo-2-oxa-3-azabicyclo[2.2.2]oct-5-ene-3-carboxylate (1.25): 
Br2 (0.20 mL, 0.40 mmol) was added to a solution of SMe2 (0.04 mL, 0.54 mmol) in CH2Cl2 (1 mL) at 0 °C.  
A precipitate formed immediately and the mixture was stirred at 0 °C for 15 min; epoxide 1.16 (30 mg, 0.10 
mmol) was then added.  The reaction was removed from the cold bath and stirred for 3 h.  The reaction 
was quenched with saturated sodium bisulfite (2 mL) and diluted with water (2 mL).  The aqueous layer 
was extracted with CH2Cl2 (3 × 3 mL).  The combined extracts were washed with brine (5 ml), dried over 
Na2SO4, filtered, and concentrated under vacuum to afford 1.25 as a yellow oil (38.4 mg, 86%).  Analytical 
data for 1.25: 1H NMR (600 MHz, CDCl3) δ 7.36 (m, 5H), 6.86 (ddd, J = 8.1, 5.9, 1.6 Hz, 1H), 6.61 (ddd, J 
= 8.1, 6.1, 2.3 Hz, 1H), 5.36 (dd, J = 6.0, 2.2 Hz, 1H), 5.25 (d, J = 12.1 Hz, 1H), 5.19 (d, J = 12.1 Hz, 1H), 
4.85 (dd, J = 6.1, 1.6 Hz, 1H), 3.79 (d, J = 11.7 Hz, 1H), 3.48 (br s, 1H), 3.17 (d, J = 11.7 Hz, 1H); 13C NMR 
(151 MHz, CDCl3) δ 196.5, 158.5, 136.8, 134.8, 128.7, 128.7, 128.4, 128.4, 77.5, 70.2, 69.07, 62.0, 35.8; 
IR (thin film, cm-1) 3303, 2361, 1744, 1271, 1082; TLC  (EtOAc:hexanes 40:60): Rf = 0.74; HRMS (ESI+):  







(1.26): OsO4 (9 mg, 0.03 mmol, 1 mol %) was added to a mixture NMO (2.45 g, 20.9 mmol) of the alkene 
1.16 (1.00 g, 3.48 mmol) in THF/acetone/H2O (5:5:1, 33 mL) at 0 °C.  After warming gradually over 4 h, the 
reaction was cooled to 0 °C and was diluted with water (20 mL).  The reaction was quenched with saturated 
sodium bisulfite (30 mL) and stirred for 30 min.  The layers were partitioned and the aqueous layer was 
extracted with EtOAc (3 × 30 mL).  The combined extracts were washed with brine (60 mL), dried over 
Na2SO4, filtered, and concentrated by rotary evaporation.  The crude material was purified through a short 
plug of silica gel (EtOAc:hexanes 70:30) to afford 1.26 as an off-white solid (1.12 g, 87%).  Analytical data 
for 26: 1H NMR (400 MHz, Acetone-d6) δ 7.51 – 7.28 (m, 5H), 5.24 (d, J = 12.5 Hz, 1H), 5.20 (d, J = 12.4 
Hz, 1H), 5.00 (d, J = 4.8 Hz, 1H), 4.95 (d, J = 5.1 Hz, 1H), 4.61 – 4.53 (m, 1H), 4.53 – 4.47 (m, 1H), 4.39 
(d, J = 4.3 Hz, 1H), 4.37 (d, J = 4.7 Hz, 1H), 3.29 (d, J = 6.2 Hz, 1H), 3.21 (d, J = 6.2 Hz, 1H); 13C NMR 
(101 MHz, Acetone) δ 201.4, 156.7, 137.0, 129.4, 129.2, 129.1, 81.3, 68.7, 66.7, 65.8, 61.9, 56.9, 52.9; IR 
(thin film, cm-1) 3341, 1758, 1710, 1249, 1051; TLC  (EtOAc:hexanes 70:30): Rf = 0.23; HRMS (ESI+):  
Calcd. for C15H15NO7Na: ([M+Na]): 344.0747, Found: 344.0735.  
 
 
2-(chloromethyl)-2,4,5,6-tetrahydroxy-3-oxocyclohexan-1-aminium chloride (1.27): A vial was 
charged with 1.26 (100 mg, 0.31 mmol) and Pd/C (10% Pd on wet charcoal, 10 wt %) then purged with N2 
for 10 min.  MeOH (2.0 mL) and AcOH (0.09 mL, 1.56 mmol) were added and vial was purged with H2 for 
10 min then stirred vigorously under a balloon of H2.  After 30 min, the reaction was filtered through a 0.45 
µm PTFE syringe filter. HCl in 1,4-dioxane (4 N, 2.00 mL) was added to the filtrate.  After stirring for 15 min 




The solid was washed with diethyl ether (2 × 10) and hexanes (2 × 10) then quickly transferred to a vial 
and placed under vacuum for 1 d to afford 27 as a white solid (53 mg, 66 %).  Note:  The title compound is 
extremely hygroscopic and will quickly (≈5-10 min) turn from a white solid to a viscous brown oil if allowed 
to stand on the fritted filter funnel.  If this happens, the oil can be dissolved in methanol and re-triturated 
with diethyl ether.    Analytical data for 1.27: 1H NMR (500 MHz, CD3OD) δ 4.50 (d, J = 7.9 Hz, 1H), 4.20 
(dd, J = 5.9, 3.4 Hz, 1H), 4.09 (d, J = 11.8 Hz, 1H), 3.95 – 3.88 (m, 2H), 3.83 (dd, J = 7.9, 3.4 Hz, 1H); 13C 
NMR (151 MHz, CD3OD) δ 206.0, 78.3, 77.0, 74.2, 69.0, 55.9; IR (thin film, cm-1) 3247, 2360, 1738, 1598, 
1052; HRMS (ESI+):  Calcd. for C7H13ClNO5: ([M-Cl]): 226.0483, Found: 226.0472. 
 
 
Benzyl 6-oxo-4a,7a-dihydro-1H,6H-spiro[furo[3,2-c][1,2]oxazine-7,2'-oxirane]-1-carboxylate (1.28): 
mCPBA (75%, 36 mg, 0.15 mmol) was added to a mixture of 1.16 (30 mg, 0.10 mmol) and NaHCO3 (17 
mg, 0.21 mmol) in CH2Cl2 (1 mL) at rt.  After stirring at rt for 16 h, the reaction was diluted with diethyl ether 
(3 mL) and washed with saturated NaHCO3 (3 × 5 mL) and brine (5 mL).  The organics were dried over 
Na2SO4, filtered, and concentrated by rotary evaporation.  The crude material was purified via flash 
chromatography on silica gel (EtOAc:hexanes, 40:60) to afford 1.28 as a yellow oil (16 mg, 51%).  Analytical 
data for 1.28: 1H NMR (400 MHz, CDCl3) δ 7.37 (m, 5H), 6.87 (d, J = 6.3 Hz, 1H), 5.71 – 5.53 (m, 1H), 5.32 
– 5.19 (m, 4H), 3.31 (d, J = 6.3 Hz, 1H), 3.08 (d, J = 6.3 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 170.5, 
154.4, 147.9, 134.7, 128.7, 128.7, 128.2, 98.7, 69.1, 66.6, 52.5, 50.6, 49.6; IR (thin film, cm-1) 3312, 1732, 
1508, 1238, 1117; TLC (EtOAc:hexanes 30:70): Rf = 0.29; HRMS (ESI+):  Calcd. for C15H13NNaO6: 








(563 mg, 6.86 mmol) in THF (20 mL) at rt.  After stirring at rt for 18 h, the reaction was diluted with water 
(20 mL) and the layers were partitioned.  The aqueous layer was extracted with EtOAc (3 × 20 mL) and the 
combined extracts were washed with brine (50 mL), dried over Na2SO4, filtered, and concentrated by rotary 
evaporation.  The crude material was purified via flash chromatography on silica gel (EtOAc:hexanes, 
40:60 to 50:50) to afford 1.29 as a yellow foam (805.0 mg, 78%).  Analytical data for 1.29: 1H NMR (600 
MHz, CDCl3) δ 7.95 (s, 1H), 7.40 – 7.30 (m, 5H), 6.81 – 6.74 (m, 1H), 6.64 (ddd, J = 8.0, 5.9, 1.9 Hz, 1H), 
6.02 (dd, J = 5.9, 1.8 Hz, 1H), 5.23 (d, J = 12.2 Hz, 1H), 5.13 (d, J = 12.2 Hz, 1H), 4.61 (dd, J = 6.0, 1.9 Hz, 
1H), 3.26 (d, J = 5.4 Hz, 1H), 3.03 (d, J = 5.4 Hz, 1H); 13C NMR (151 MHz, CDCl3) δ 158.1, 150.1, 135.2, 
130.3, 128.6, 128.5, 128.4, 128.3, 68.5, 66.8, 58.9, 54.8, 52.5; IR (thin film, cm-1) 3367, 3066, 1715, 1265, 





(1.30): NaBH4 (8 mg, 0.20 mmol) was added to a solution of 1.29 (30 mg, 0.10 mmol) in anhydrous 
MeOH (1 mL) at rt.  After stirring at rt for 30 min, the reaction was quenched with saturated NH4Cl (5 
mL).  The aqueous layer was extracted with EtOAc (3 × 5 mL), and the combined extracts were washed 
with brine (10 mL), dried over Na2SO4, filtered, and concentrated by rotary evaporation.  The 
crude material was purified via flash chromatography on silica gel (EtOAc:hexanes, 70:30) to afford 1.30 as 
a yellow foam (102 mg, 51%).  Analytical data for 1.30: 1H NMR (600 MHz, CDCl3) δ 8.07 (s, 1H), 7.39 – 
7.30 (m, 5H), 6.88 – 6.66 (m, 1H), 6.54 (ddd, J = 8.0, 6.0, 1.9 Hz, 1H), 5.92 (dd, J = 6.0, 1.5 Hz, 1H), 5.22 
(d, J = 12.2 Hz, 1H), 5.16 – 5.09 (m, 2H), 3.95 (dd, J = 11.0, 6.7 Hz, 1H), 3.89 – 3.81 (m, 1H), 2.75 (s, 1H), 
2.62 (ddd, J = 7.9, 6.7, 2.9 Hz, 1H); 13C NMR (151 MHz, CDCl3) δ 158.8, 153.8, 135.9, 135.3, 128.7, 128.6, 
128.5, 128.2, 68.4, 66.1, 62.7, 53.2, 40.3; IR (thin film, cm-1) 3365, 1732, 1716, 1698, 1272, 1074; TLC  








3-carboxylate (1.31): Anhydrous triethylamine (0.06 mL, 0.45 mmol) was added to a mixture of 1.30 (34 
mg, 0.11 mmol), DMAP (1 mg, 0.01 mmol, 10 mol %), and p-nitrobenzoyl chloride (62 mg, 0.34 mmol) in 
anhydrous THF (1 mL).  The reaction was stirred under N2 for 2 d at rt.  The reaction was diluted with water 
(3 mL) and the aqueous layer was extracted with EtOAc (3 × 3 mL).  The combined extracts were washed 
with brine (5 mL), dried over Na2SO4, filtered, and concentrated by rotary evaporation.  The crude residue 
was purified by flash chromatography on silica gel (EtOAc:hexanes 15:85 to 20:80) to afford 1.31 as a 
crystalline yellow solid.  Analytical data for 1.31: 1H NMR (500 MHz, CDCl3) δ 8.39 – 8.31 (m, 2H), 8.29 – 
8.18 (m, 6H), 7.42 – 7.29 (m, 5H), 7.00 – 6.89 (m, 1H), 6.65 (ddd, J = 8.1, 6.1, 1.9 Hz, 1H), 6.02 (dd, J = 
6.1, 1.5 Hz, 1H), 5.33 – 5.28 (m, 1H), 5.20 (d, J = 12.1 Hz, 1H), 5.17 (d, J = 12.1 Hz, 1H), 4.93 (dd, J = 
11.2, 6.1 Hz, 1H), 4.72 (dd, J = 11.2, 9.2 Hz, 1H), 3.25 (ddd, J = 9.2, 6.0, 3.0 Hz, 1H); 13C NMR (151 MHz, 
CDCl3) δ 164.1, 161.3, 161.0, 150.9, 150.6, 135.0, 134.9, 133.6, 130.9, 130.8, 128.7, 128.7, 128.7, 128.3, 
127.6, 123.9, 123.9, 123.9, 123.6, 68.8, 67.5, 64.3, 53.1, 38.2, 38.1; IR (thin film, cm-1) 1748, 1732, 1716, 
1523; TLC  (EtOAc:hexanes 50:50): Rf = 0.59; HRMS (ESI+):  Calcd. for C29H22N4NaO11: ([M+Na]): 






(1.32): Anhydrous THF (1 mL) was added to a flame dried vial containing Me3SO+I-(23 mg, 0.12 mmol) 
under N2.  NaH (60 wt % in mineral oil, 4 mg, 0.11 mmol) was added in one portion.  After stirring for 20 




(0.5 mL) was added via syringe.  After stirring at 0 °C for 2 h, the reaction was quenched with saturated 
NH4Cl (5 mL) and diluted with diethyl ether (3 mL).  The layers were partitioned and the aqueous layer was 
extracted with diethyl ether (3 × 5 mL).  The combined extracts were washed with brine (10 mL), dried over 
Na2SO4, filtered, and concentrated by rotary evaporation.  The crude material was purified via flash 
chromatography on silica gel (EtOAc:hexanes, 15:85 to 20:80) to afford 1.32 as a white, amorphous 
solid (18.6 mg, 59%).  The relative stereochemistry was determined by 2D-NOESY analysis.   Analytical 
data for 1.32: 1H NMR (400 MHz, CDCl3) δ 7.41 – 7.29 (m, 5H), 6.76 (ddd, J = 8.1, 5.8, 1.9 Hz, 1H), 6.71 
(ddd, J = 8.1, 5.4, 2.0 Hz, 1H), 5.24 (d, J = 12.2 Hz, 1H), 5.14 (d, J = 12.2 Hz, 1H), 4.58 (dd, J = 5.8, 2.0 
Hz, 1H), 4.37 (dd, J = 5.4, 1.9 Hz, 1H), 2.94 (d, J = 4.6 Hz, 1H), 2.82 (d, J = 4.6 Hz, 1H), 2.80 (d, J = 4.7 
Hz, 1H), 2.70 (d, J = 4.7 Hz, 1H); 13C NMR (151 MHz, CDCl3) δ 158.0, 135.2, 132.1, 131.6, 128.6, 128.5, 
128.5, 128.3, 75.3, 68.5, 58.8, 58.2, 57.5, 49.9, 48.2; IR (thin film, cm-1) 3065, 3031, 2925, 1716; TLC  





oxirane]-6-carboxylate (1.34):  OsO4 (2 mg, 0.01 mmol, 1 mol %) was added to a mixture NMO (577 mg, 
4.93 mmol) of the 1.19 (3.4:1 mixture of diastereomers, 300 mg, 0.82 mmol) in THF/acetone/H2O (5:5:1, 
11 mL) at rt.  The reaction was stirred for 2.5 h then placed in a water bath.  The reaction was quenched 
with saturated sodium bisulfite (10 mL) and stirred for 30 min (exothermic).  The mixture was diluted with 
water and the aqueous layer was extracted with diethyl ether (3 × 20 mL).  The combined extracts were 
washed with brine (30 mL), dried over Na2SO4, filtered, and concentrated by rotary evaporation.  The crude 
material was purified by flash chromatography on silica gel (EtOAc:hexanes, 30:70 to 50:50) to afford 1.34 
as an inseparable mixture of diastereomers (1.1:1 dr determined by 1H NMR) as viscous colorless oil (231 
mg, 70%).  The diastereomer ratio was determined by comparison of the integration of the resonances at 




are reported. Analytical data for 1.34:  Major isomer, 1H NMR (600 MHz, CDCl3) δ 7.42 – 7.30 (m, 10H), 
5.28 (d, J = 12.0 Hz, 1H), 5.23 – 5.12 (m, 3H), 4.41 – 4.34 (m, 3H), 4.14 (dd, J = 8.5, 6.7 Hz, 1H), 3.20 (d, 
J = 6.0 Hz, 1H), 3.12 – 3.08 (m, 1H), 3.03 (d, J = 5.8 Hz, 1H), 2.97 (d, J = 5.9 Hz, 1H), 2.90 (d, J = 5.8 Hz, 
1H), 2.92 – 2.83 (m, 3H), 2.50 (hept, J = 7.0 Hz, 1H), 2.37 (hept, J = 7.0 Hz, 1H), 1.60 (s, 6H), 1.05 (d, J = 
7.0 Hz, 3H), 1.03 – 0.99 (m, 6H), 0.87 (d, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 203.5, 201.5, 
157.9, 157.6, 135.2, 135.1, 128.7, 128.7, 128.6, 128.5, 128.5, 128.4, 128.3, 87.5, 85.9, 69.0, 69.0, 68.5, 
68.4, 68.1, 67.3, 64.6, 64.3, 60.7, 59.3, 49.9, 47.6, 27.4, 25.5, 16.5, 16.3, 15.9, 15.3, 15.2, 14.1; IR (thin 
film, cm-1), 345, 2974, 1753, 1711, 1385, 1293, 1057; TLC  (EtOAc:hexanes 50%): Rf = 0.37; HRMS (ESI+):  




[4,7](epoxyimino)benzo[d][1,3]dioxole]-8'-carboxylate (1.35):  PTSA (10 mol %, 5.0 mg, 0.027 mmol) 
was added to a solution of diol 1.34 (1.1:1 dr, 100 mg, 0.27 mmol) in acetone/2,2-DMP (1:1, 1.4 ml).  The 
reaction was heated and stirred at 40 °C for 2.5 h.  The reaction was cooled to rt then quenched with 
saturated sodium bicarbonate (3 ml).  The aqueous layer was extracted with ether (3 × 3 ml).  The 
combined extracts were washed with brine (5 ml), dried over Na2SO4, filtered, and concentrated by rotary 
evaporation.  The crude material was purified by flash chromatography on silica gel (EtOAc/hexanes 
10:90 to 15:85 then ether) to afford 1.35 as an inseparable mixture of diastereomers as a yellow oil (1.2:1 
dr, 95 mg, 86%).  The diastereomer ratio was determined by comparison of the integration of the 
resonances at δ 2.46 (major diastereomer) and δ 2.32 (minor diastereomer).  Note:  The combined 1H 
and 13C spectra are reported.   Analytical data for 1.35:  1H NMR (600 MHz, CDCl3) δ 7.42 – 7.30 (m, 9H), 
5.28 (d, J = 12.0 Hz, 1H), 5.23 – 5.14 (m, 3H), 4.59 – 4.53 (m, 3H), 4.39 (d, J = 6.8 Hz, 1H), 3.29 (d, J = 
6.1 Hz, 1H), 3.01 (d, J = 6.1 Hz, 1H), 2.97 (d, J = 6.1 Hz, 1H), 2.86 (d, J = 6.1 Hz, 1H), 2.46 (hept, J = 7.0 
Hz, 1H), 2.32 (hept, J = 7.0 Hz, 1H), 1.64 (s, 3H), 1.61 (s, 2H), 1.33 (s, 3H), 1.33 (s, 3H), 1.30 (s, 3H), 




CDCl3) δ 202.0, 200.2, 157.8, 157.6, 135.3, 135.2, 128.7, 128.6, 128.5, 128.4, 128.2, 111.7, 111.1, 86.5, 
84.8, 76.5, 76.0, 74.3, 74.1, 68.4, 68.4, 63.7, 63.7, 59.7, 58.3, 50.8, 48.0, 28.3, 25.9, 25.6, 25.3, 24.4, 
24.1, 16.6, 16.3, 16.1, 16.0, 15.7, 15.1; IR (thin film, cm-1) 2978, 2940, 2360, 1756, 1723, 1383, 1268, 
1211, 1081, 1051; TLC  (EtOAc:hexanes 40:60): Rf = 0.77; HRMS (ESI+):  Calcd. for C22H28NO7: ([M+H]): 



























1D-NOESY Determination of Diastereomers: 
 
Selective 1D-NOESY Correlation Experiment - (1H, 600 MHz, CDCl3) 
 
The mixture of isomers was determined to be diastereomers resulting from the facial approach of the 
acylnitroso dienophile.  The black spectrum (5) is the mixture of diastereomers.  Selective excitation of 
each epoxide resonance revealed a correlation to the bridgehead methyl in both diastereomers A and B 
(spectrum 3 and 2 respectively) but only diastereomer A exhibited a correlation between the epoxide and 
the acetonide methyl (4). 
 
Diastereomer B – no observable 
epoxide correlation to acetonide 
methyl 
Diastereomer B – epoxide 
correlation to bridgehead methyl 
Diastereomer A – epoxide 
correlation to bridgehead methyl 
Diastereomer A – epoxide 




Cross-over experiment:  
 
A solution of tBuO2CNHOH (77 mg, 0.58 mmol) in CH2Cl2 (1 mL) was added via syringe pump over 2 h to 
a mixture of 1.19 (3.4:1 dr, 20 mg, 0.06 mmol) and nBu4NIO4 (252 mg, 0.58 mmol) in CH2Cl2 (1 mL) at rt.  
After complete addition, the reaction was diluted with MTBE (4 mL) and the mixture was filtered through a 
plug of Celite®.  The filtrate was concentrated by rotary evaporation and the crude residue was purified by 
flash chromatography on silica gel (EtOAc:hexanes 10:90 to 20:80) to afford an inseparable mixture of 37 
and 1.36 (mixture of diastereomers, no yield recorded).  The 1H NMR spectrum of the mixture of products 
matched an independently synthesized mixture of 1.33 and 1.36 (prepared using a modified General 
Procedure A in which BnO2CNHOH is exchanged for tBuO2CNHOH).  The 1H spectrum of the 






Acylnitroso Diels–Alder Cycloaddition Facial Selectivity: 
When cycloadduct 1.16 was heated between 40-65 °C for 50 h, a mixture of diastereomers was formed 
and the newly formed diastereomer could be isolated. This indicated the initially observed isomer 
(confirmed by X-ray diffraction analysis) was the kinetically favored product.  Furthermore, the crystal 
structures of cycloadducts 1.9, which results from acylnitroso approach from the methylene face, exhibit a 
degree of twisting in the [2.2.2]-bicyclic core.  In contrast, cycloadducts 1.14 and 1.16, which result from 
acylnitroso approach from the oxygen face, exhibit very little twisting.  We contend that acylnitroso approach 
from the oxygen face of the epoxide is kinetically favored while approach from the methylene face is 
thermodynamically favored.  This is further supported by the diminished initial diastereoselectivities (pre-
equilibration) observed for cycloadducts 1.11 and 1.19 and the slow isomerization observed for cycloadduct 



















After heating at 40-65 
°C for 50 h 
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Chapter Two: Oxidative Dearomatization/Acylnitroso Diels–Alder Cycloaddition Cascade:  An 
Approach Toward the Total Synthesis of (±)-Tetrodotoxin 
 
2.1 Introduction 
2.1.1 Previous Syntheses of Tetrodotoxin 
 A number of creative strategies have been employed in the syntheses of densely functionalized 
cyclohexane scaffolds resembling “tetrodamine” 2.2, a conceptual intermediate en route to tetrodotoxin 
(TTX, 2.1).1-10 Previous syntheses utilize a “traditional” synthetic approach, in which densely functionalized 
cyclohexane scaffolds are synthesized via an iterative functional group installation/protection sequence.  
This approach has proven successful, but requires a lengthy synthesis. Furthermore, this approach 
necessitates the challenging late-stage installation of the nitrogen at C8a; a transformation that is often a 
key, route-defining step.  With the exception of the synthesis of TTX by Sato,10 installation of nitrogen at 
C8a has been achieved through a number of intramolecular strategies (Scheme 2-1). Fukayama achieved 
this challenging transformation through dehydration of carbamate 2.3 and subsequent [3,3]-sigmatropic 
rearrangement of the intermediate allylic cyanate.  Trapping the resultant isocyanate with LiOtBu afforded 
N-Boc amine 2.4.9 Isobe accessed oxazolidinone 2.6 through base-promoted aza-Michael addition of 
carbamate 2.5.5 A late-stage intramolecular Rh–nitrene C–H insertion furnished oxazolidinone 2.8 in the 
synthesis of (–)-TTX by Du Bois while Beckman rearrangement of oxime 2.9 to amide 2.10 provided 
intramolecular installation of the nitrogen in the seminal synthesis of racemic TTX by Kishi.  In contrast, the 
deployment of our developed oxidative dearomatization/acylnitroso Diels–Alder cycloaddition cascade 
could allow for an expedient synthesis of a densely functionalized cyclohexane scaffold, analogous to 
“tetrodamine” 2.2, by capitalizing on the latent functionality embedded in the bezenoid nucleous.  A further 
advantage of this strategy was the intermolecular installation of the nitrogen at C8a relatively early in the 







Scheme 2-1.  Intramolecular Installation of the Nitrogen at C8a 
 
rapidly installed and a “traditional” synthetic strategy, proceeding through an iterative functional group 
installation/protection sequence, presented unique challenges.  Application of the oxidative 
dearomatization/acylnitroso Diels–Alder cycloaddition cascade toward the synthesis of (±)-TTX (2.1) 
required the development of three distinct stages; 1) synthesis of a more complex benzenoid relative to 




of the cyclohexane scaffold (Scheme 2-2).  The chemical reactivity, synthetic strategy, and inherent 
challenges associated with each stage is detailed herein. 
Scheme 2-2. Oxidation/Cycloaddition Cascade – Development of Three Stages 
 
2.2 Synthesis of a Functionalized Benzenoid Starting Material  
 Potential extrapolation of the developed oxidative dearomatization/cycloaddition cascade reaction 
toward the synthesis of (±)-TTX would require the deployment of a more functionalized benzenoid starting 
material.  Toward that aim, salicyl alcohol 2.16 was in initially prepared from 2,5-dimethylphenol 2.11 by 
former group member Robert Sharpe (Scheme 2-3).  Ortho-directed bromination and TBS protection 
afforded protected bromophenol 2.12.  Bis-benzylic bromination/acetoxylation furnished bis-acetate 2.13 
which underwent global reduction and selective protection to afford bis-siloxy phenol 2.14.  Subsequent 
ortho-lithiation/formylation gave salicylaldehyde 2.15.  Reduction of aldehyde 2.15 and  





chemoselective oxidative TES deprotection afforded salicyl alcohol 2.16. Although salicyl alcohol 2.16 
provided the corresponding acylnitroso Diels–Alder cycloadduct through both the sequential and one-pot 
oxidative dearomatization/cycloaddition (vide infra), the lithiation/formylation of bromophenol 2.14 suffered 
from irreproducibility, necessitating the need for a second generation route.  Our initial efforts relied on the 
ortho-functionalization of 2,3-dimethylphenol 2.17 (Scheme 2-4).  Kolbe–Schmidt carboxylation11 and 
subsequent acetonide protection afforded salicylate 2.18.  Bis-acetate salicylate 2.19 was synthesized  
 Scheme 2-4.  Synthesis of Salicyl Alcohol 2.16 from 2,3-Dimethylphenol  
 
through the bromination/acetoxylation sequenced developed in the first generation route.  However, neither 
selective deprotection nor selective reduction of the aryl ester in the presence of the benzylic acetates was 
achieved.  Concurrently, we investigated the synthesis of salicyl alcohol 2.16 from 2,3,6-trimethylphenol 
2.22 utilizing a similar benzylic bromination/acetoxylation strategy (Scheme 2-5).  Although global benzylic 
bromination did provide entry to triol 2.24, we were unable to develop conditions for the regioselective 
tBu2PhSi mono-protection of the 6-hydroxymethyl, isolating a mixture of regioisomers (3-hydroxymethyl vs. 
6-hydroxymethyl) and bis-protection. Furthermore, triol 2.24 was unstable, decomposing upon storage at –
20 °C.  At this juncture, we postulated that exhaustive bromination could afford hexabromophenol 2.26.  
Subsequent global hydrolysis of the benzylic gem- 





dibromides and ortho-directed reduction of the resultant tris-aldehyde 2.27 with BH3 would afford diol 2.28 
(Scheme 2-6).  Selective protection of the less sterically encumbered 6-hydroxymethyl functionality and 
subsequent reduction would afford desired salicyl alcohol 2.16.  Toward this aim, tribromophenol 2.15  
Scheme 2-6.  Proposed Exhaustive Bromination/Hydrolysis  
 
was resubjected to benzylic bromination in the presence of three equivalents of NBS, yielding 
pentabromophenol 2.29 as both a single product/regioisomer (Scheme 2-7).  Subsequent acetoxylation 
afforded gem-dibromo salicylaldehyde 2.30, serendipitously differentiating each of the three benzylic 
positions.  Interestingly, bromination of TBS-protected trimethylphenol 2.25 with NBS (5-6 equiv) 
Scheme 2-7. Benzylic Bromination/Acetoxylation of 2,3,6-Trimethylphenol 
 
furnished a mixture of pentabromophenol 2.29 and tetrabromophenol 2.31, formed as a single regioisomer.  
While the ratio of 2.29 to 2.31 could be perturbed according to the equivalents of NBS, we were unable to 
obtain either bromophenol as a single product on multigram scale when starting from TBS-protected 
trimethylphenol 2.17.  Acetoxylation of the inseparable mixture of 2.29 and 2.31 afforded a separable 
mixture of gem-dibromo salicylaldehyde 2.30 and bis-acetate salicylaldehyde 2.32, respectively.  Both bis-
acetate salicylaldehyde 2.32 and gem-dibromo salicylaldehyde 2.30 provided access to salicyl alcohol 2.16 
(Scheme 2-8).  Following the sequential bromination/acetoxylation sequence, reduction of bis-acetate 
salicylaldehyde 2.32 gave bis-acetate salicyl alcohol 2.25.  Subsequent protection of the benzylic alcohol 




2.30 furnished salicyl alcohol 2.34 in excellent yield.  Protection of the benzylic alcohol and subsequent 
hydrolysis of the gem-dibromide afforded aldehyde 2.35 in good yield over two steps.  Global reduction of 
aldehyde 2.35 similarly afforded triol 2.16. The use of Me2NH•BH3 for the reduction of bis-acetate aldehyde  
Scheme 2-8. Second Generation Synthesis of Salicyl Alcohol 2.16 
 
2.32 and gem-dibromo aldehyde 2.30 was crucial; NaBH4 led to the reductive elimination of the ortho-
benzylic acetate, presumably via base-mediated quinone methide formation and subsequent reduction.  
Although converging two products into one route was not ideal, the second generation route circumvented 
the troublesome lithiation/formylation previously described in Scheme 2-3.  Furthermore, this second 
generation route was required minimal purification by column chromatography, expediting material 
throughput.  Without interference from the distal benzylic alcohol, the desired cycloadduct 2.36 was 
prepared with excellent facial selectivity through the action of both the sequential and one-pot Adler 
oxidation/ANDA procedures on salicyl alcohol 2.16 (Scheme 2-9). The relative stereochemistry of 2.36 was 
confirmed via X-ray crystallographic analysis.12 The oxidative dearomatization/cycloaddition procedure was 




Scheme 2-9. Application of the Oxidative Dearomatization/Acylnitroso Diels–Alder Cycloaddition Toward 
Tetrodotoxin 
 
2.3 Functionalization of the [2.2.2]-Bicycle Scaffold 
 Elaboration of cycloadduct 2.36 toward tetrodamine would require a number of functional group 
manipulations.  Many of the late-stage intermediates detailed herein could be intercepted through multiple 
different synthetic sequences, resulting in a complex, branched synthetic tree.  Accordingly, subsequent 
sections are organized by the functional group manipulations outlined in Figure 2-1. 
Figure 2-1.  Functional Group Manipulations Needed to Access Tetrodamine from the [2.2.2]-Bicycle 
Scaffold 
 
2.3.1 Dihydroxylation of the [2.2.2]-Bicycle Scaffold 
 Given the promising diastereoselective OsO4 catalyzed dihydroxylation of cycloadduct 1.16 
(Chapter One, Scheme 1-4) we pursued dihydroxylation of the alkene as the initial functional group 
transformation en route to tetrodamine.  Dihydroxylation of cycloadduct 2.36 afforded triol 2.37 with 
excellent facial selectivity (Scheme 2-10).12 The dihydroxylation was scalable and triol 2.37 could be 
isolated without column chromatography. Subsequent TsOH catalyzed acetonide protection gave 
undesired dioxane 2.38 while catalytic I2 at 40 °C allowed for the thermodynamically favored syn-1,2-diol 
protection, affording dioxolane 2.39 in excellent yield.  Protection of the syn-1,2-diol was later found to 





Scheme 2-10. Alkene Dihydroxylation of the [2.2.2]-Bicycle Scaffold 
 
2.3.2 Installation of the Glycolate in the [2.2.2]-Bicycle Scaffold 
 We envisioned installation of the glycolate functionality via oxidation of cycloadduct 2.36 to 
unsaturated aldehyde 2.40 followed by nucleophilic addition of a masked carboxylate synthon, such as 
akynyl/alkenyl organometallic species, nitromethane, and cyanide (Scheme 2-11).  Functional group 
interconversion of addition product 2.41 would afford the desired unsaturated glycolate 2.42.  An identical 
sequence could be employed for the functionalization of dioxolane 2.39.  Furthermore, should the 
nucleophilic addition to unsaturated aldehyde 2.40 and/or dioxolane aldehyde 2.43 afford the undesired  
Scheme 2-11. Proposed Installation of the Glycolate via Nucleophilic Addition  
 
diastereomer, stereo-correction could be achieved through re-oxidation and subsequent reduction.  We 
began by investigating the nucleophilic addition to unsaturated aldehyde 2.40, prepared from oxidation of 
cycloadduct 2.36 (Scheme 2-12). Addition of lithium TMS-acetylide to 2.40 afforded propargylic alcohol 
2.46 with poor facial selectivity while addition of ethynylmagnesium bromide resulted in an intractable 




nitroaldol product, affording oxazolidinone 2.47 as a single diastereomer while the addition in THF resulted 
in decomposition.  These results indicated the diastereoselective nucleophilic addition to  
Scheme 2-12.  Nucleophilic Addition to Unsaturated Aldehyde 2.40 
 
unsaturated aldehyde 2.40 would be a challenging endeavor, thus the nucleophilic addition to dioxolane 
aldehyde 2.43, obtained from IBX oxidation of 2.39 (Scheme 2-13) was explored.  Conversion of aldehyde 
2.43 to the TES cyanohydrin 2.48 under phase transfer catalysis was unsuccessful yielding largely 
decomposition products BnOH and tBuPh2SiOH with a trace conversion to a mixture of what appeared to 
be diastereomers.  Addition of ethynlmagnesium bromide to 2.43 proceeded with subsequent cyclization, 
affording propargylic oxazolidinone 2.49 in high diastereoselectivity, albeit for the incorrect diastereomer 
(determined by X-ray crystallographic analysis).  The addition of vinylmagnesium bromide similarly 
proceeded with subsequent cyclization, yielding allylic oxazolidinone 2.51.  While we were unable to 
oxidatively cleave propargylic oxazolidinone 2.49 to glycolate 2.50, allylic oxazolidinone 2.51 underwent 
ozonolysis in the presence of methanolic KOH13 to afford methyl glycolate 2.52 (incorrect glycolate 
diastereomer), establishing sequential vinylmagnesium bromide/ozonolysis as a viable approach for the 
installation of the glycolate functionality.   Formation of the oxazolidinone prevented stereo-correction via 
re-oxidation/reduction and would necessitate a potentially challenging hydrolysis at a later point in the 
synthesis.  For this reason, we proposed installation of the glycolate through conversion of dioxolane 
aldehyde 2.43 to 1,1-di-X alkene 2.46 (Scheme 2-14).  Subsequent dihydroxylation would, in theory, afford 
the desired glycolate diastereomer, assuming dihydroxylation of 1,1-di-X alkene 2.43 exhibited analogous 





Scheme 2-13. Nucleophilic Addition to Dioxolane Aldehyde 2.43 
 
Toward this aim dibromomethyl Wittig olefination14 and malononitrile Knoevenagel condensation were 
investigated.  Dibromomethyl Wittig olefination of dioxolane aldehyde 2.43 gave no reaction while attempts 
to achieve a Knoevenagel condensation resulted in decomposition.   Subjecting less sterically encumbered  





unsaturated aldehyde 2.40 to dibromomethyl Wittig olefination returned similar results; decomposition was 
observed in the absence of additives while no reaction was observed with Zn additive.13 Dibromomethyl 
Wittig olefination of aromatic aldehyde 2.35 (Scheme 2-8) was successful.  These results collectively 
indicated that the nucleophilic addition of “large” nucleophiles to [2.2.2]-bicyclic aldehyde analogs was 
sterically inhibited while the addition of “small” nucleophiles without concurrent cyclization was challenging.  
Ultimately, we elected to forgo installation of the glycolate functionality in the [2.2.2]-bicyle scaffold due to 
the challenging diastereoselective nucleophilic addition paired with the inability to reductively cleave the N–
O bond of dioxolane protected analogs (see section 2.3.4). 
2.3.3 Ring Opening of the Epoxide and Ketone Reduction in the [2.2.2]-Bicycle Scaffold 
 Although a number of Lewis acids have been demonstrated to promote rearrangement of epoxides 
to ketones and aldehydes,15-17 the regiochemistry of the rearrangement is intimately tied to the stability of 
the intermediate carbocation.  Under this reaction manifold, rearrangement of the epoxide in our system 
would necessitate prior reduction of the ketone as the α-ketocarbocation would be unfavorable.  An 
alternative approach would be the formal reduction of the epoxide.  However, hydride reduction of epoxides 
typically proceeds through hydride attack at the less hindered carbon, affording the more substituted 
alcohol.  To overcome these challenges, SmI2 promoted reductive opening of α,ß-epoxyketone 2.39 was 
investigated (Scheme 2-15).18 Treatment of 2.39 in the absence a protic additive yielded a ~1:1 mixture of 
desired ß-hydroxy ketone 2.58 (>20:1 dr) and enone 2.59, arising from retro-aza–Michael addition. 





Addition of tBuOH to the reaction system inhibited the deleterious elimination, affording 2.58 as a single 
product.  Alternatively, the primary alcohol could be masked via base-promoted intramolecular cyclization, 
affording oxazolidinone 2.60.  Subsequent reductive ring opening proceeded in the absence a protic 
additive, yielding ß-hydroxy ketone 2.61 with excellent diastereoselectivity.  Reduction with NaBH4 afforded 
diol 2.62 with good facial selectivity.  Despite these results, further derivatization was not pursued due to 
the inability to reductively cleave the N–O bond in 2.58 or 2.61. 
2.3.4 Reductive N–O bond cleavage 
 Drawing from the successful reductive cleavage of oxazinane (N–O bond) 1.26 in Chapter One 
(Scheme 1-4), we initially investigated Pd/C catalyzed hydrogenolysis of triol 2.37 (Scheme 2-16).  A 
scalable modified hydrogenolysis procedure was developed, affording lactol 2.63 in good yield without the  
Scheme 2-16. Pd/C Catalyzed Hydrogenolysis of Triol 2.37 
 
need for purification by column chromatography.  However, neither selective N-Boc protection (2.64) nor 
selective acetonide protection of the syn-1,2-diol (2.65), protecting groups commonly employed in previous 
synthesis of TTX,1-10 was achieved (see section 2.4.1 for further detail).  Consequently, we explored 
reductive cleavage of the N–O bond in analogs 2.39, 2.40, 2.58, and 2.60 (Scheme 2-17) with an emphasis 
on Pd-catalyzed hydrogenolysis.  Under all but two conditions (see footnote), neither deprotection of the 
Cbz group nor cleavage of the N–O bond was observed, demonstrating the resiliency of 2.39, 2.40, and 
2.58 toward Pd-catalyzed hydrogenolysis.  Oxazolidinone 2.60 was similarly inert under Pd-catalyzed 







Scheme 2-17. Failed Reductive Cleavage of the N–O Bond in [2.2.2]-Bicycle Analogs 
 
boride reduction, and Mo(CO)6  promoted reductive cleavage.  At this point, we elected to pursue further 
functionalization of unprotected lactol 2.63 (Scheme 2-16) toward tetrodamine 2.2, abandoning the 
reductive N–O bond cleavage in analogs 2.39, 2.43, 2.58, and 2.59. 
2.4. Functionalization of the Cyclohexane Scaffold 
2.4.1 Protection of the syn-1,2-Diol and Amine Functionality in the Cyclohexane Scaffold 
 Elaboration of lactol 2.63 to tetrodamine would require installation of the glycolate functionality, 
reduction of the lactol/ketone, and rearrangement of the epoxide (Scheme 2-18).   
Scheme 2-18. Functional Group Manipulations Required to Access Tetrodamine from the Cyclohexane 
Scaffold 
 
Prior to these manipulations, protection of the reactive amine and syn-1,2-diol would need to be 
investigated.  Boc protection of the amine and dioxolane protection of the syn-1,2-diol were ideal due to 




alcohols has been thoroughly documented and thus represented an appealing initial approach; however, 
N-Boc protection of lactol 2.63 in the absence of a nucleophilic catalyst failed to afford N-Boc lactol 2.64, 
returning only unreacted 2.63 (Scheme 2-19).  Inclusion of catalytic DMAP with 1 equivalent of Boc2O  
Scheme 2-19.  Chemoselective N-Boc Protection of Lactol 2.63 
 
furnished a complex mixture of products, likely resulting from competitive O-Boc protection.  These results 
collectively indicated that nucleophilic attack of sterically congested amine 2.63 upon Boc2O was inhibited 
while O-Boc protection was competitive in the presence of DMAP.  In light of these results, chemoselective 
protection of the 1,2-diol in the presence of the free amine was investigated.  Acetonide protection with both 
stoichiometric and catalytic acid failed to afford desired dioxolane 2.65, affording dioxane 2.70 instead 
(Scheme 2-20).  Similar to the N-Boc protection of lactol 2.63 in Scheme 2-19, N-Boc protection of 
Scheme 2-20. Chemoselective 1,2-Diol Protection of Lactol 2.63 
 
dioxane 2.70 in the absence of DMAP gave no reaction while inclusion of DMAP afforded a mixture of N-
Boc and O-Boc products.  The 1,2-diol of lactol 2.63 could be selectively protected as the 4-
methoxybenzylidene acetal 2.71 in the presence of stoichiometric acid; however, this reaction suffered from 




with the hypothesis that a less sterically hindered electrophile would allow for N-protection of lactol 2.63 in 
the presence of the 1,2-diol.  Indeed, CbzCl allowed for the chemoselective N-Cbz protection of lactol 2.63, 
affording Cbz lactol 2.72 (Scheme 2-21).  Subsequent regioselective protection of the 1,2-diol with catalytic 
I2 furnished dioxolane 2.73 in good yield. 
Scheme 2-21. Chemoselective N-Cbz Protection and 1,2-Diol Dioxolane Protection of lactol 2.63 
 
 
2.4.2 Installation of the Glycolate Functionality in the Cyclohexane Scaffold 
 With Cbz-dioxolane lactol 2.73 in hand, installation of the glycolate functionality was investigated 
using the sequential vinyl Grignard addition/ozonolysis protocol outlined in section 2.3.2.  Application of this 
strategy necessitated prior cleavage of the lactol and oxidation of the resultant primary alcohol.  Toward 
this aim, reductive cleavage of lactol 2.73 afforded diol 2.74 with excellent diastereoselectivity (Scheme 2-
22).  Subsequent oxidation with TPAP proceeded with over-oxidation to lactone 2.75 while oxidation under 
ABNO conditions19 furnished hemiacetal 2.76.  Surprisingly, addition of vinylmagnesium chloride to 
hemiacetal 2.76 afforded chlorohydrin 2.77.  Looking to circumvent formation of ketal 2.76 and subsequent 





chlorohydrin formation, the oxidative cleavage of lactol 2.73 was investigated.  Oxidation of lactol 2.73 with 
IBX gave a mixture of ketoaldehyde 2.79 and hydrate 2.78 (Scheme 2-24).  The mixture was dehydrated 
with 3Å molecular sieves, providing ketoaldehyde 2.79 as a single product.  Addition of vinylmagnesium 
chloride to ketoaldehyde 2.79 furnished allylic lactol 2.80 with high facial selectivity for the undesired 
diastereomer.  However, complete consumption of ketoaldehyde 2.79 was not observed, even in the 
Scheme 2-23. Oxidative Cleavage and Vinyl addition to Lactol 2.73 
 
presence of excess vinylmagnesium chloride, returning a mixture of unreacted 2.79 and hydrate 2.78. With 
the suspicion that the tertiary alcohol was linked to the incomplete conversion, bis-dioxolane ketoaldehyde 
2.83 was prepared from Cbz-dioxolane lactol 2.73 (Scheme 2-24).  Vinyl magnesiumbromide addition to 
2.83 afforded unsaturated bis-dioxolane lactol 2.84 with full conversion and high facial selectivity for the 
undesired diastereomer.  Ozonolysis of tBuPh2Si allylic lactol 2.80 and bis-dioxolane analog 2.84 in the 
presence of methanolic KOH furnished tBuPh2Si glycolate 2.85 and bis-dioxolane glycolate 2.87 
respectively (Scheme 2-25).  Stereo-correction of tBuPh2Si glycolate 2.85 through re-oxidation/reduction 





was not achieved; oxidation to methyl α-ketoester 2.86 with IBX gave no reaction. However, stereo-
correction of bis-dioxolane glycolate 2.87 was achieved through DMP oxidation to α-ketoester 2.88 and 
subsequent reduction to epimer 2.89.  Interestingly, epimeric bis-dioxolane glycolate 2.89 did not undergo 
further reduction in the presence of 2 equivalents of NaBH4. 
Scheme 2-25.  Installation of the Glycolate Functionality via Ozonolysis in the Cyclohexane Scaffold 
 
2.4.3 Reductive Epoxide Opening Ketone Reduction in the Cyclohexane Scaffold 
 Reductive opening of the epoxide and diastereoselective reduction of the ketone were challenging 
functional group manipulations in the cyclohexane scaffold.  Similar to the strategy deployed in the [2.2.2]-
bicycle stage (see section 2.3.3), we initially investigated the SmI2 promoted reductive cleavage of the 
Figure 2-2.  Analogs Investigated for the Epoxide Opening and Ketone Reduction in the Cyclohexane 
Scaffold   
 
α,ß-epoxyketone analogs 2.90, 2.93, 2.85, and 2.89 (Figure 2-2). Reduction of TES epoxyketone 2.90, 
prepared from Cbz-dioxolane lactol 2.81, afforded enone 2.91 as a single product in the presence of 
methanol as a protic additive while inclusion of acetic acid and water as co-additives furnished an 
approximate 1.6:1 mixture of enone 2.91 and desired ß-hydroxy ketone 2.92 (1.2:1 dr) (Scheme 2-26).  





Scheme 2-26. SmI2 Promoted Reductive Opening of TES Epoxyketone 2.92 
 
the absence of a protic additive, afforded ß-hydroxy ketone 2.94 with excellent diastereoselectivity and no 
observable enone formation (Scheme 2-27).  Interestingly, 1D NOESY analysis indicated ß-hydroxyketone 
2.94 adopts a boat conformation, prohibiting elimination to the enone due to insufficient orbital overlap of 
the α-C–H δ-bond and the π*(C=O) of the carbonyl.  Subsequent protection of the ß-hydroxyketone 2.95 
and diastereoselective reduction of the ketone with tBuNH2•BH3 afforded secondary alcohol 2.95.  However, 
this route was not pursued further as we were unable to N-Boc protect oxazolidinone 2.95, a key protection 
required to activate the oxazolidinone toward hydrolysis.8   
Scheme 2-27. SmI2 Promoted Reductive Opening of Oxazolidinone Epoxyketone 2.93 
 
Reduction of tBu2PhSi glycolate lactol 2.85 (incorrect glycolate diastereomer) and bis-dioxolane glycolate 
lactol 2.89 with SmI2 in the presence of methanol afforded trace conversion to enone 2.97 and 2.98 at -78 
°C (Scheme 2-28).  Presumably, equilibration to the ketone is significantly slower at this temperature.  




temperature in the absence of a proton donor, similar to the conditions employed for the reduction of 
oxazolidinone 2.94 (Scheme 2-27), yielded iodohydrin 2.99 as a single observable product. However,  
Scheme 2-28.  SmI2 Promoted Reductive Opening of Glycolate Lactols 2.85 and 2.89 
addition of bis-dioxolane glycolate 2.89 to a solution of SmI2 at ambient temperature afforded a 1.2:1 mixture 
of ketolactone 2.100 (tentative structure) and iodohydrin 2.99.  In order to reveal the α,ß-epoxyketone and 
promote efficient reduction of the epoxide with SmI2, we attempted to protect the bis-dioxolane glycolate 
2.89 (Scheme 2-29).  Acetate protection did afford trace conversion to the α-acetoxy glycolate 2.101 but 
was accompanied by a large degree of decomposition, as judged by the relative integration against DMAP 
in the crude 1H NMR spectrum.  TES protection failed to give α-silyloxy glycolate 2.102, returning only 
Scheme 2-29. Lactol Cleavage via Protection of Glycolate 2.85 and 2.89 
 
unreacted 2.89.  While we were investigating the SmI2 promoted reductive opening of the epoxyketone, we 




hypothesizing that epoxy alcohols 2.103 and 2.106 could be cyclized to afford epoxy lactones 2.104 and 
2.107 respectively (Scheme 2-30).  Subsequent reduction of the epoxide with Cp2TiCl20 would afford 
Scheme 2-30.  Proposed Lactol Reduction and Cp2TiCl Promoted Reductive Epoxide Opening 
 
the primary alcohol 2.105 and  2.108.  However, reduction of tBu2PhSi glycolate lactol 2.85 and bis-
acetonide analog 2.89 with NaBH4 both resulted in a mixture of products with reduction of the ester as the 
major product (Scheme 2-31).  Reduction of bis-dioxolane lactol 2.89 yielded no reaction with NaBH3CN 
nor catechol borane while reduction with tBuNH2•BH3 furnished epoxy alcohol 2.106 as a 1:1 mixture of 
diastereomers. 









In conclusion, we have investigated the viability of the oxidative dearomatization/acylnitroso Diels–
Alder cycloaddition developed in Chapter One toward the total synthesis of (±)-tetrodotoxin through the 
development of three stages.  In the first stage, an exhaustive bromination/acetoxylation sequence was 
developed in order to synthesize salicyl alcohol 2.16 bearing functionality amenable to elaboration toward 
TTX.  Elaboration of densely functionalized cycloadduct 2.36 and lactol 2.63 toward tetrodamine 2.2 was 
investigated in the second stage and third stage, respectively.  Investigation of the reactivity of both 
cycloadduct 2.36 and lactol 2.63 identified a number of challenges, ultimately enabling the synthesis of 
complex, late-stage intermediates 2.85 and 2.89 bearing a marked resemblance to tetrodamine 2.2.  
Further development of this synthetic strategy should allow for the total synthesis of (±)-tetrodotoxin.     
2.6 Experimental Details 
Methods 
General:  Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier transform infrared 
spectrometer. Proton and carbon magnetic resonance spectra (1H NMR and 13C NMR) were recorded on 
a Bruker model Avance 400 (1H NMR at 400 MHz), Bruker Avance III 500 (1H NMR at 500 MHz and 13C 
NMR at 126 MHz), or a Bruker Avance III 600 (1H NMR at 600 MHz and 13C NMR at 151 MHz) spectrometer 
with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.26 ppm, (CD3)2CO at 2.05 ppm, 
CD3OD at 3.31 ppm; 13C NMR: CDCl3 at 77.0 ppm, CD2Cl2 at 53.5 ppm, (CD3)2CO at 206 ppm, CD3OD at 
49 ppm). 1H NMR data are reported as follows: chemical shift, multiplicity (s = singlet, br s = broad singlet, 
d = doublet, t = triplet, q = quartet, hept = heptet, dd = doublet of doublets, ddd = doublet of doublet of 
doublets, dq = doublet of quartets, m = multiplet), coupling constants (Hz), and integration. Mass spectra 
were obtained using a Thermo LTqFT mass spectrometer with electrospray introduction and external 
calibration unless otherwise noted. All samples were prepared in methanol. Analytical thin layer 
chromatography (TLC) was performed on Sorbent Technologies 250 µm glass-backed Silica Gel TLC 
plates. Visualization was accomplished with UV light, KMnO4, ceric ammonium molybdate (CAM), and/or 
Seebach’s stain followed by heating. Purification of the reaction products was carried out by flash 
chromatography using Siliaflash-P60 silica gel (40-63μm) purchased from Silicycle. Unless otherwise 




to isolated yield of analytically pure material unless otherwise noted. Yields are reported for a specific 
experiment and as a result may differ slightly from those found in figures, which are averages of at least 
two experiments.  
Materials:  
General:  Solvents were not dried prior to use unless specified as “anhydrous.” Anhydrous tetrahydrofuran 
(THF), diethyl ether (Et2O), and dichloromethane (CH2Cl2) were dried by passage through a column of 
neutral alumina under nitrogen prior to use.  Anhydrous dimethylformamide (DMF) was purchased from 
Sigma-Aldrich and was used as received.  Ethyl acetate (EtOAc) was purchased from Fisher Scientific and 
was used as received. 
Experimental Procedures: 
Select experimental procedures are included for compounds shown in Scheme 2-8 (section 2.2) and 
Scheme 2-32 (below).  Full characterization (1H NMR, 13C NMR, FTIR, and mass spectrometry) data is 























Tert-butyldimethyl(2,3,6-trimethylphenoxy)silane (2.25): Imidazole (112 g, 1.65 mol) was added to a 
solution of 2,3,6-trimethylphenol (75 g, 0.55 mol) in anhydrous DMF (2 L).  TBSCl (183 g, 1.21 mol) was 
added and the mixture was stirred under a stream of N2 at rt for 2 d.  The reaction was slowly quenched by 
adding saturated sodium bicarbonate (1 L).  The aqueous layer was extracted with hexanes (3 × 800 mL).  
The combined extracts were divided into two roughly equal portions and each portion was washed with 1 
N NaOH (2 × 400 mL) followed by brine (400 mL).  The portions were combined, dried over Na2SO4, 




TBSOH was removed under vacuum at 80 °C to afford 2.25 (142 g, 94.7 % wt, 97% corrected) with some 
residual (TBS)2O.   
 
Alternative procedure:  Imidazole (100 g, 1.47 mol) was added to a solution of 2,3,6-trimethylphenol (100 
g, 0.73 mol) in anhydrous CH2Cl2 (1.85 L).  TBSCl (133 g, 0.88 mol) was added and the mixture was stirred 
under N2 overnight (18h).  The reaction mixture was transferred to a separatory funnel and was washed 
with 1 N NaOH (2 x 900 ml).  The CH2Cl2 layer was dried over Na2SO4, decanted, and concentrated via 
rotary evaporation to afford a mixture of 2.25 and residual TBSOH.  The TBSOH was removed under 
vacuum at 80 °C to afford 2.25 (184 g, 95 % wt, 95% corrected). 
Analytical data for 2.25: 1H NMR (400 MHz, CDCl3) δ 6.86 (d, J = 7.6 Hz, 1H), 6.71 (d, J = 7.6 Hz, 1H), 2.21 
(s, 3H), 2.18 (s, 3H), 2.11 (s, 3H), 1.04 (s, 9H), 0.17 (s, 6H); 13C NMR (151 MHz, CDCl3) δ 151.6, 135.5, 
127.6, 127.3, 126.0 122.7, 26.1, 25.7, 25.6, 20.2, 18.7, 17.7, 13.9, -3.07; IR (thin film, cm-1) 2955, 2930, 
2858, 1462, 12472, 1088, 919; TLC  (EtOAc:hexanes 5:95): Rf = 0.70; HRMS (APPI+, atmospheric pressure 
photoionization):  Calcd. for C15H26OSi: ([M]): 250.1753, Found: 250.1751. 
 
 
(4-formyl-3-hydroxy-1,2-phenylene)bis(methylene) diacetate (2.32); 6-(dibromomethyl)-3-formyl-2-
hydroxybenzyl acetate (2.30): AIBN (2.08 g, 12.66 mmol, 15 mol %) and NBS (15.0 g, 84.4 mmol) were 
added to a solution of 2.25 (5.00 g, 18.8 mmol) in benzene (190 mL).  The mixture was purged with a 
stream of N2 then heated to reflux.  The reaction was stirred for 4 h then cooled to rt and diluted with 




The resultant solution was then filtered through a short plug of silica gel (EtOAc:hexanes 1:99 as eluent) 
and the filtrate was concentrated via rotary evaporation to afford a mixture of 2.31 and 2.29. 
Anhydrous NaOAc (15.4 g, 188 mmol) and water (15.2 mL, 844 mmol) were added to the mixture of 2.31 
and 2.29 in glacial acetic acid (95 mL).  The mixture was heated to 100 °C and was stirred under N2 for 4 
h.  The reaction was cooled to rt and diluted with water (95 mL).  The aqueous layer was extracted with 
diethyl ether (3 × 50 mL) and the combined extracts were washed with water (3 × 50 mL) and brine (50 
mL), dried over Na2SO4, filtered, and concentrated via rotary evaporation.  The crude material was purified 
via flash chromatography on silica gel (EtOAc:hexanes 10:90 to 30:70) to afford 2.32 as a white solid (1.5 
g, 30.0% two steps) and 2.30 as a yellow oil which slowly solidified up storage at -20 °C (1.75 g, 25.5 % 
two steps).   
Analytical data for 2.32: 1H NMR (400 MHz, CDCl3) δ 11.48 (s, 1H), 9.91 (s, 1H), 7.59 (d, J = 8.0 Hz, 1H), 
7.10 (d, J = 8.0 Hz, 1H), 5.30 (s, 2H), 5.25 (s, 2H), 2.13 (s, 3H), 2.08 (s, 3H); 13C NMR (151 MHz, CDCl3) 
δ 196.2, 170.9, 170.4, 160.6, 145.2, 134.3, 122.3, 120.2, 120.0, 63.2, 56.46, 20.90; IR (thin film, cm-1) 3178, 
1741, 1654, 1624, 1228, 1028; TLC  (EtOAc:hexanes 60:40): Rf = 0.79; HRMS (ESI+):  Calcd. for C13H15O6: 
([M+H]): 267.0869, Found: 267.0864.   
Analytical data for 2.30: 1H NMR (400 MHz, CDCl3) δ 11.67 (s, 1H), 9.93 (s, 1H), 7.71 (d, J = 8.2 Hz, 1H), 
7.67 (d, J = 8.2 Hz, 1H), 7.13 (s, 1H), 5.37 (s, 2H), 2.13 (s, 3H); 13C NMR (151 MHz, CDCl3) δ 195.9, 170.8, 
159.8, 149.2, 134.5, 121.2, 120.3, 119.1, 55.1, 36.3, 20.9; IR (thin film, cm-1) 3055, 1733, 1653, 1224, 1026; 




(3-hydroxy-4-(hydroxymethyl)-1,2-phenylene)bis(methylene) diacetate (2.33):  Me2NH•BH3 (0.288 g, 
4.88 mmol) was added to a solution of 2.32 (1.00 g, 3.76 mmol) in diethyl ether.  The reaction was heated 
and stirred at 50 °C for 1.5 h then cooled to rt.  The reaction was quenched via the addition of 1 N HCl (20 
mL).  The biphasic mixture was stirred vigorously for 15 min (until no further H2 evolution was observed) 




combined extracts were washed with brine (20 mL), dried over Na2SO4, filtered, and concentrated via rotary 
evaporation.  The crude material was purified via flash chromatography on silica gel (EtOAc:hexanes 30:70 
to 50:50) to afford 2.33 as a white solid (716 mg, 74%).  Analytical data for 2.33: 1H NMR (400 MHz, CDCl3) 
δ 8.55 (s, 1H), 7.21 (d, J = 7.7 Hz, 1H), 6.96 (d, J = 7.7 Hz, 1H), 5.26 (s, 2H), 5.19 (s, 2H), 4.77 (d, J = 6.2 
Hz, 2H), 2.50 (t, J = 6.2 Hz, 1H), 2.10 (s, 3H), 2.10 (s, 3H); 13C NMR (151 MHz, CDCl3) δ 173.4, 170.7, 
155.0, 136.6, 129.3, 128.6, 121.8, 121.1, 63.9, 63.2, 58.5, 21.0, 21.0; IR (thin film, cm-1) 3291, 1734, 1716, 
1238, 1024; TLC  (EtOAc:hexanes 50:50): Rf = 0.39; HRMS (ESI+):  Calcd. for C13H16NaO6: ([M+Na]): 
291.0845, Found: 291.0834. 
 
 
(4-(((tert-butyldiphenylsilyl)oxy)methyl)-3-hydroxy-1,2-phenylene)dimethanol (2.16):  TBDPSCl (1.08 
mL, 4.10 mmol) was added to a mixture of 2.33 (1.00 g, 3.73 mmol), DMAP (46 mg, 0.37 mmol, 10 mol %), 
and imidazole (508 mg, 7.46 mmol) in anhydrous CH2Cl2 (20 mL) at rt under N2.  The reaction was stirred 
at rt for 20 h then diluted with hexanes (20 mL) and filtered through a plug of Celite®.  The filtrate was 
concentrated via rotary evaporation.  The crude residue was dissolved in anhydrous diethyl ether (20 mL) 
and placed under N2.  BH3•THF (1 M, 14.9 mL, 14.9 mmol) was added slowly at rt and the reaction was 
then heated and stirred at 45 °C for 2 h.  The reaction was cooled to rt and slowly quenched with 1 N HCl 
(20 mL).  The mixture was stirred vigorously for 1 h then the layers were partitioned.  The aqueous layer 
was extracted with diethyl ether (2 × 20 mL) then the combined extracts were washed with brine, dried over 
Na2SO4, filtered, and concentrated via rotary evaporation.  The crude residue was purified via flash 
chromatography on silica gel (EtOAc:hexanes 60:40) to afford 2.16 as a colorless foam (806 mg, 51%).  
Note:  incomplete hydrolysis of the borate ester was occasionally observed in the crude 1H NMR spectrum 
and the borate could be isolated after flash chromatography.  If incomplete hydrolysis of the borate is 
observed, the crude residue can be dissolved in THF and stirred vigorously with saturated ammonium 
chloride solution (≈1:1 v/v) for 16 h without deleterious effects on the yield.  Analytical data for 2.16: 1H NMR 




= 7.8 Hz, 1H), 6.79 (d, J = 7.8 Hz, 1H), 4.92 (s, 2H), 4.87 (s, 2H), 4.68 (s, 2H), 2.94 (br s, 1H), 2.82 (br s, 
1H), 1.08 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 155.1, 140.1, 135.5, 131.8, 130.2, 128.0, 126.6, 126.1, 
124.5, 120.6, 66.1, 64.0, 56.8, 26.7, 19.10; IR (thin film, cm-1) 3310, 2930, 2857, 1112, 1045, 998; TLC  




6-(dibromomethyl)-2-hydroxy-3-(hydroxymethyl)benzyl acetate (2.34):  Me2NH•BH3 (1.22 g, 20.7 
mmol) was added to a solution of 2.30 (6.31 g, 17.2 mmol) in diethyl ether (85 mL).  The reaction was 
heated to 45 °C and stirred for 1 h then cooled to rt.  The reaction was quenched via the addition of 1 N 
HCl (90 mL).  The biphasic mixture was stirred vigorously for 20 min (until no further H2 evolution was 
observed) then the layers were partitioned and the aqueous layer was extracted with diethyl ether (2 × 50 
mL).  The combined extracts were washed with brine (100 mL), dried over Na2SO4, filtered, and 
concentrated via rotary evaporation to afford 2.34 as a flocculent white solid (6.04 g, 95%).  Analytical data 
for 2.34: 1H NMR (500 MHz, CDCl3) δ 8.46 (s, 1H), 7.56 (d, J = 7.0 Hz, 1H), 7.31 (d, J = 8.0 Hz, 1H), 7.04 
(s, 1H), 5.33 (s, 2H), 4.84 (d, J = 6.0 Hz, 2H), 2.37 (t, J = 6.0 Hz, 1H), 2.16 (s, 3H); 13C NMR (151 MHz, 
CDCl3) δ 172.9, 153.9, 142.2, 129.8, 129.0, 121.9, 117.6, 63.2, 57.1, 37.3, 20.9; IR (thin film, cm-1) 3267, 
1725, 1246, 1024; TLC  (EtOAc:hexanes 50:50): Rf = 0.56; HRMS (ESI+):  Calcd. for C11H12Br2NaO4: 
([M+Na]): 388.9000, Found: 388.8997. 
 
 
3-(((tert-butyldiphenylsilyl)oxy)methyl)-6-formyl-2-hydroxybenzyl acetate (2.35):  TBDPSCl (0.40 mL, 




mixture was stirred for 5 min then 2.34 (500 mg, 1.36 mmol) was added in one portion. The reaction was 
stirred at rt for 4 h then diluted with hexanes (10 mL) and filtered through a plug of Celite®.  The filtrate was 
concentrated by rotary evaporation.  The crude residue was dissolved in a mixture of MeCN (7.5 mL), AcOH 
(7.50 mL), H2O (7.50 mL), 1,4-dioxane (2.50 mL).  Anhydrous NaOAc (669 mg, 8.15 mmol) were added to 
the solution and the resulting mixture was heated to 80 °C and stirred for 3 h  under N2.  The reaction was 
cooled to rt and was diluted with water (25 mL).  The aqueous layer was extracted with diethyl ether (3 × 
20 mL).  The combined extracts were washed with water (3 × 20 mL) and brine (20 mL), dried over Na2SO4, 
filtered, and concentrated by rotary evaporation.  The crude residue was purified via flash chromatography 
on silica gel (EtOAc:hexanes, 5:95 to 20:80) to afford 2.35 as a yellow oil (370 mg, 59%).  Analytical data 
for 2.35: 1H NMR (500 MHz, CDCl3) δ 10.17 (s, 1H), 8.84 (s, 1H), 7.71 – 7.65 (m, 4H), 7.53 – 7.49 (m, 1H), 
7.48 – 7.42 (m, 3H), 7.42 – 7.36 (m, 4H), 5.59 (s, 2H), 4.91 (s, 2H), 2.10 (s, 3H), 1.11 (s, 9H); 13C NMR 
(151 MHz, CDCl3) δ 192.3, 173.3, 154.6, 135.5, 134.7, 134.6, 132.3, 130.0, 127.9, 127.5, 125.7, 121.4, 
63.6, 57.0, 26.8, 20.9, 19.3; IR (thin film, cm-1) 2931, 2857, 1702, 1692, 1242, 1113; TLC  (EtOAc:hexanes 
50:50): Rf = 0.89; HRMS (ESI+):  Calcd. for C27H35NNaO7Si: ([M+Na]): 485.1761, Found: 485.1751. 
 
 
(4-(((tert-butyldiphenylsilyl)oxy)methyl)-3-hydroxy-1,2-phenylene)dimethanol (2.16):  BH3•THF (1 M, 
3.12 mL, 3.12 mmol) was slowly added to a solution of 2.35 (361 mg, 0.78 mmol) in anhydrous diethyl ether 
(3.5 mL) at rt under a stream of N2.  The reaction was heated and stirred at 50 °C for 2 h.  The reaction was 
cooled to rt and slowly quenched with 1 N HCl (5 mL).  The biphasic mixture was stirred vigorously for 1 h.  
The layers were partitioned and the aqueous layer was extracted with diethyl ether (2 × 5 mL).  The 
combined extracts were washed with brine, dried over Na2SO4, and concentrated by rotary evaporation.  
The crude residue was dissolved in THF (5 mL) and saturated ammonium chloride solution (5 mL) was 
added.  The mixture was stirred overnight to ensure complete hydrolysis of the borate(s).  The mixture was 
diluted with water (5 mL) and the aqueous layer was extracted with diethyl ether (3 × 5 mL).  The combined 




evaporation.  The crude residue was purified via flash chromatography on silica gel (EtOAc:hexanes, 60:40) 




azaspiro[bicyclo[2.2.2]octane-2,2'-oxiran]-7-ene-6-carboxylate (2.36):   
One-pot Procedure: 
Water (17 mL) and NaIO4 (1.90 g, 8.87 mmol) were added to a mixture of 2.16 (0.74 g, 1.74 mmol) and N-
benzyl-N,N,N-triethylammonium chloride (20 mol %) in CH2Cl2 (13 mL).  The mixture was stirred vigorously 
overnight (~19 h).  A solution of BnO2CNHOH (1.16 g, 6.96 mmol) in CH2Cl2 (9 mL) was added over 3 h 
via syringe pump.  After complete addition, the reaction was stirred for 15 min then water (10 mL) was 
added and the layers were partitioned.  The aqueous layer was extracted with diethyl ether (2 × 20 mL) and 
the combined extracts were washed with brine (30 ml), dried over Na2SO4, filtered, and concentrated via 
rotary evaporation.  The crude residue was purified via flash chromatography on silica gel (CH2Cl2) to afford 
2.36 as a white solid (0.46 g, 45%) which was recrystallized by slow evaporation from acetone/hexanes to 
afford colorless crystals suitable for X-ray crystallography.   
 
Sequential Procedure:  
 
Water (30 mL) and NaIO4 (3.04 g, 14.2 mmol) were added to a solution of 2.16 (5.00 g, 11.8 mmol) in MeOH 
(60 mL).  The reaction was stirred for 1 h (a white precipitate forms).  The reaction was filtered and the 
filtrate was diluted with water (60 mL) and the aqueous layer was extracted with Et2O (3 × 60 mL).  The 
extracts were washed with brine (100 ml), dried over Na2SO4, filtered, and concentrated by rotary 




(90 ml) then water (115 ml), N-benzyl-N,N,N-triethylammonium chloride (20 ml %), and NaIO4 (5.31 g, 24.8 
mmol) were added.  The mixture was cooled to 0 °C and a solution of BnO2NHOH (3.96 g, 23.7 mmol) in 
CH2Cl2 (60 mL) was added over 2 h via syringe pump.  After complete addition, the reaction was allowed 
to warm gradually for 20 min.  The layers were partitioned and the aqueous layer was extracted with CH2Cl2 
(2 x 50 ml).  The combined extracts were dried over sodium sulfate, filtered, and concentrated via rotary 
evaporation to afford a brown oil.  Residual solvent was removed via azeotropic distillation with hexanes 
until a brown solid was obtained.  The solid was transferred to a fritted filter funnel and was washed with 
minimal ice-cold methanol (3×) to afford the desired product as an amorphous white powder. 
Analytical data for 2.36: 1H NMR (400 MHz, CDCl3) δ 7.72 (dt, J = 6.8, 1.2 Hz, 4H), 7.48 – 7.27 (m, 11H), 
7.04 (d, J = 8.4 Hz, 1H), 6.78 (d, J = 8.4 Hz, 1H), 5.37 (d, J = 12.2 Hz, 1H), 4.93 (d, J = 12.2 Hz, 1H), 4.34 
(d, J = 12.7 Hz, 1H), 4.12 – 4.05 (m, 3H), 3.75 (t, J = 7.9 Hz, 1H), 3.34 (d, J = 5.9 Hz, 1H), 3.11 (d, J = 5.9 
Hz, 1H), 1.06 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 195.7, 159.3, 139.5, 135.6, 135.6, 135.0, 132.5, 132.4, 
130.0, 129.8, 128.6, 128.5, 128.1, 127.9, 127.7, 127.0, 85.6, 68.7, 67.0, 59.6, 59.1, 55.1, 50.2, 26.6, 19.2; 
IR (thin film, cm-1) 3274, 2931, 1759, 1698, 1299, 1113; TLC  (EtOAc:hexanes 50:50): Rf = 0.52; HRMS 




azaspiro[bicyclo[2.2.2]octane-2,2'-oxirane]-6-carboxylate (2.37): OsO4 (0.05 mol %) was added to a 
mixture of NMO (4.30 g, 36.7 mmol) and 2.36 (4.30 g, 7.35 mmol) in THF/acetone/H2O (5:5:1, 33 ml) at rt.  
The reaction was stirred for 3 h then placed in a water bath and quenched with saturated sodium bisulfite 
(30 mL).  The mixture was stirred for 30 min then transferred to a 500 ml Erlenmeyer flask.  Water (300 ml) 
was added and the mixture was stirred for 10 minutes resulting in the formation of a beige precipitate.  The 
precipitate was collected via filtration and the filtrate was washed with minimal ice-cold methanol (3×) and 
hexanes (3 × 10 ml) to afford the hydrate of the 2.37 as a white, amorphous solid (3.31 g, 73%).  The 
hydrate could be stirred with 3 Å molecular sieves in CHCl3 (the mixture will gradually turn from a silky, 




Note:  The title ketone could also be isolated after purification by flash chromatography (EtOAc:hexanes 
40:60 to 60:40, dry load) as a white solid.  Analytical data for 2.37: 1H NMR (500 MHz, CDCl3) δ 7.76 – 7.65 
(m, 4H), 7.46 – 7.29 (m, 11H), 5.39 (d, J = 12.1 Hz, 1H), 5.04 (d, J = 12.1 Hz, 1H), 4.78 (d, J = 6.8 Hz, 1H), 
4.66 (d, J = 6.8 Hz, 1H), 4.35 (d, J = 12.7 Hz, 1H), 4.02 (m, 2H), 3.84 (d, J = 12.7 Hz, 1H), 3.17 (d, J = 6.0 
Hz, 1H), 2.89 (d, J = 6.0 Hz, 1H), 1.05 (s, 9H); 13C NMR (151 MHz, CD2Cl2) δ 200.9, 156.7, 135.6, 135.6, 
135.3, 132.5, 132.4, 130.0, 129.9, 128.7, 128.6, 128.4, 127.9, 127.8, 85.7, 68.7, 67.5, 67.2, 64.3, 59.3, 
59.1, 58.6, 48.7, 26.5, 19.1; IR (thin film, cm-1) 3446, 2931, 2857, 1758, 1683, 1113; TLC  (EtOAc:hexanes 




2,3,4,5-tetraol (2.63): AcOH (0.69 mL, 12.0 mmol) and a MeOH/THF (3:2, 25 mL) solution was added to a 
mixture of dry Pd/C (10 wt % Pd loading, 10 wt %) and 2.37 (1.53 g, 2.4 mmol) under N2.  Note:  The Pd/C 
was dried under vacuum at 60 °C for 4 h before use.  The mixture was purged with H2 for 5 min then stirred 
vigorously under a balloon of H2 for 1 h.  The reaction was purged with N2 and filtered through a plug of 
Celite®.  The filtrate was neutralized with saturated NaHCO3 (30 ml) and the aqueous layer was extracted 
with EtOAc (3 × 20 mL).  The combined extracts were washed with brine (20 mL), dried over Na2SO4, 
filtered, and concentrated by rotary evaporation.  The crude residue was purified via flash chromatography 
on silica gel (EtOAc then MeOH:CH2Cl2, 5:95 to 10:90) to afford 2.63 as a colorless oil which could be 
isolated as a white, amorphous solid after azeotropic evaporation (3×) from hexanes (0.81 g, 69%). 
Analytical data for 2.63: 1H NMR (500 MHz, CDCl3) δ 7.72 – 7.64 (m, 4H), 7.50 – 7.35 (m, 6H), 4.21 (d, J 
= 10.9 Hz, 1H), 4.14 (d, J = 7.9 Hz, 1H), 4.08 – 4.01 (m, 2H), 3.95 (d, J = 5.4 Hz, 1H), 3.56 (d, J = 7.9 Hz, 
1H), 3.24 (d, J = 4.2 Hz, 1H), 3.06 (d, J = 4.2 Hz, 1H), 2.99 (s, 1H), 2.74 (s, 1H), 1.08 (s, 9H); 13C NMR 
(151 MHz, CDCl3) δ 135.6, 132.3, 132.3, 130.1, 127.9, 102.6, 73.1, 71.1, 64.7, 63.5, 58.7, 47.0, 26.8, 19.3; 
IR (thin film, cm-1) 2931, 2857, 2348, 1737, 1727, 1428, 1112; TLC  (MeOH:CH2Cl2 10:90): Rf = 0.38; HRMS 







oxaspiro[bicyclo[3.2.1]octane-8,2'-oxiran]-1-yl)carbamate (2.72): CbzCl (3.03 ml, 21.3 mmol) was 
added to a mixture of 2.63 (9.887 g, 20.3 mmol) and NaHCO3 (5.110 g, 60.8 mmol) in anhydrous THF (100 
ml) under N2.  The mixture was stirred at rt overnight (18 h).  The reaction was quenched by the addition of 
water (50 ml).  The layers were partitioned and the aqueous layer was extracted with Et2O (3 x 50 ml).  The 
combined extracts were washed with brine (100 ml), dried over Na2SO4, filtered, and concentrated via rotary 
evaporation.  The crude residue was purified via flash chromatography of silica gel (EtOAc:hexanes 30:70 





(2.73): I2 (0.443 g, 10 mol %) was added to a solution of 2.72 (10.853 g, 17.5 mmol) in acetone at rt.  The 
mixture was stirred at rt for 90 min.  The reaction was quench by adding saturated Na2S2O3 solution (30 
ml).  The layers were partitioned and the aqueous layer was extracted with Et2O (3 x 30 ml).  The combined 
extracts were washed with brine (100 ml), dried over Na2SO4, filtered, and concentrated via rotary 
evaporation to afford 2.73 as an off-white solid.  Note:  a second minor product is observed by 1H NMR, 
likely the 1,3-dioxane from protection of the 1,3-diol.  This impurity co-eludes with the 2.73 during 







dimethyl-6-oxotetrahydro-4H-spiro[benzo[d][1,3]dioxole-5,2'-oxiran]-4-yl)carbamate (2.79): IBX 
(187.9 mg, 0.67 mmol) was added to a solution of 2.73 (222.0 mg, 0.36 mmol) and AcOH (5.8 µL, 1.00 
mmol) in EtOAc (2 ml).  The reaction was sealed and stirred at 75 °C for 6 h.  The reaction was cooled to 
rt, diluted with Et2O (6 ml) and the filtered through a plug of silica gel (EtOAc:hexanes 50:50).  The filtrate 
was concentrated via rotary evaporation to afford a mixture of hydrate 2.78 and desired aldehyde 2.79.  
The mixture was dissolved in CH2Cl2 (1 ml) and stirred over activated 3Å molecular sieves overnight (17 
h).  The solution was drawn into a 3 ml syringe and was filtered through a PTFE syringe filter.  The filtrate 
was concentrated via rotary evaporation to afford 2.79 as a white foam (180.1 mg, 81%).  Note: 2.79 forms 






yl)carbamate (2.80): A solution of vinyl magnesiumchloride in anhydrous THF (1.6 M, 0.69 ml, 1.10 mmol) 
was added drop-wise to a solution of 2.79 (347.0 mg, 0.52 mmol) in anhydrous THF (3 ml) under an N2 
atmosphere at -78 °C.  After complete addition, the reaction was stirred for 30 minutes then quenched with 
saturated NH4Cl solution (3 ml).  The mixture as warmed to rt and the layers were partitioned.  The aqueous 
layer was extracted with Et2O (3 x 3 ml).  The combined extracts were washed with brine (5 ml), dried over 




flash chromatography (EtOAc:hexanes 20:80 to 40:60) to afford recovered 2.79 (partially hydrated) and 





[4,7]methano[1,3]dioxolo[4,5-d]oxepine]-5'-carboxylate (2.85): A solution of KOH (70.2 mg, 1.25 mmol) 
in MeOH (3 ml) was added to a solution of 2.80 (172.1 mg, 0.25 mmol) in CH2Cl2 (3 ml) at -78 °C.  An O3 
enriched O2 (3-5% O3) stream was bubbled through the solution (the solution immediately turns orange) 
until 2.80 was consumed by TLC (EtOAc:hexanes 50:50).  Note:  the blue color associated with ozonolysis 
is often not observed during this reaction.  The reaction was quenched by adding saturated NH4Cl solution 
(3 ml) followed by Et2O (5 ml) at -78 °C.  The mixture was removed from the cold bath and was warmed to 
rt while stirring vigorously.  The layers were partitioned and the aqueous layer was extracted with Et2O (3 
x 5 ml).  The combined extracts were washed with brine (10 ml), dried over Na2SO4, filtered and 
concentrated.  The product was purified by flash chromatography (EtOAc:hexanes 40:60 to 50:50) to afford 




[4,7]methano[1,3]dioxolo[4,5-d]oxepine-8',4''-[1,3]dioxolan]-4'(5'H)-yl)carbamate (2.81): TBAF•H2O 
(3.990 g, 0.013 mol) was added to a solution of 2.73 (8.590 g, 0.013 mmol) in anhydrous THF (65 ml).  The 
reaction was stirred at rt for 10 min then quenched with saturated NH4Cl (30 ml).  The layers were partitioned 
and the aqueous layer was extracted with EtOAc (2 x 30 ml).  The combined extracts were washed with 




dissolved in EtOAc and filtered through a plug of silica gel (EtOAc).  The filtrate was concentrated via rotary 
evaporation and residual EtOAc was removed by azeotropic distiallation with acetone (2 x).  The crude 
residue was dissolved in acetone (50 ml) and I2 (240.1 mg, 7 mol %) was added.  The reaction was stirred 
for 30 minutes then quenched with saturated Na2S2O3 (30 ml) and diluted with Et2O (40 ml).  The layers 
were partitioned and the aqueous layer was extracted with Et2O (2 x 40 ml).  The combined extracts were 
washed with brine, dried over sodium sulfate, filtered, and concentrated via rotary evaporation to afford 




dispiro[oxirane-2,6'-benzo[d][1,3]dioxole-4',4''-[1,3]dioxolan]-7'-yl)carbamate (2.83): DMP (1.559 g, 
3.68 mmol) was added to a solution of 2.81 (1.420 g, 3.06 mmol) in CH2Cl2 (20 ml).  The mixture was stirred 
at rt for 90 min then diluted with hexanes (20 ml) and Et2O (10 ml).  The resultant mixture was filtered 
through a plug of silica gel (EtOAc:hexanes 50:50).  The filtrate was concentrated via rotary evaporation to 
~10 ml at which point a white precipitate was observed.  The mixture was filtered through a second plug of 
silica gel (EtOAc:hexanes 50:50) and the filtrate was concentrated via rotary evaporation to afford a mixture 
of hydrate 2.82 and desired aldehyde 2.83. The crude residue was dissolved in anhydrous PhH (10 ml) and 
was stirred over activated 3Å molecular sieves overnight (18 h) in a sealed vial.  The solution was filtered 
through a cotton plug into a flame-dried round bottom flask and the filtrate was concentrated via rotary 
evaporation to afford 2.83 (1.131 g, 80%) as a white solid with a small amount of residual 1-hydroxy-1,2-
benziodoxol-3(1H)-one  (byproduct from the DMP oxidation).  The product was used without further 
purification.  Note:  2.83 will form hydrate 2.82 upon prolonged exposure to moist air and should be used 








yl)carbamate (2.84): A solution of vinyl magnesiumchloride in anhydrous THF (1.9 M, 2.4 ml, 4.65 mmol) 
was added drop-wise to a solution of 2.83 (1.130 g, 2.45 mmol) in anhydrous THF (15 ml) under an N2 
atmosphere at -78 °C.  After complete addition, the reaction was stirred for 30-45 minutes then quenched 
with AcOH (1.4 ml, 24.49 mmol) in Et2O (15 ml).  The mixture was filtered through a plug of Celite® and 
the filtrate was concentrated via rotary evaporation.  The crude reside was dissolved in PhH (10 ml) and 
was filtered through a second plug of Celite®.  The filtrate was concentrated to afford 2.84 as a white solid 





[1,3]dioxolane]-5'-carboxylate (2.87): A solution of KOH ( 0.656 g, 11.68 mmol) in MeOH (8 ml) was 
added to a solution of 2.84 (1.144 g, 2.34  mmol) in CH2Cl2 (8 ml) at -78 °C.  An O3 enriched O2 (3-5% O3) 
stream was bubbled through the solution (the solution immediately turns orange) until 2.84 was consumed 
by TLC (EtOAc:hexanes 50:50, ~2h).  Note:  the blue color associated with ozonolysis is often not observed 
during this reaction.  The reaction was quenched by adding 1 N HCl (23 ml, 23.37 mmol) and Et2O (20 ml).  
The mixture was removed from the cold bath and was warmed to rt while stirring vigorously.  The layers 
were partitioned and the aqueous layer was extracted with Et2O (3 x 20 ml).  The combined extracts were 




The product was purified by flash chromatography (EtOAc:hexanes 40:60 to 50:50) to afford 2.87 as a white 





oxoacetate (2.88): DMP (0.708 g, 1.67 mmol) was added to a solution of 2.87 (0.580 g, 1.11 mmol) in 
CH2Cl2 (5 ml) at rt.  The vial was sealed and the reaction was stirred at 40 °C for 24 h.  Cooled the reaction 
to rt quenched the reaction by adding saturated NaHCO3 (4 ml) and saturated Na2S2O3 (4 ml).  The mixture 
was stirred until it became homogeneous then the layers were partitioned.  The aqueous layer was 
extracted with CH2Cl2 (2 x 4 ml).  The combined extracts were washed with brine (6 ml), dried over Na2SO4, 
filtered and concentrated via rotary evaporation.  The crude residue was dissolved premixed 
EtOAc:hexanes (40:60) and was filtered through a plug of silica gel (EtOAc:hexanes 40:60 eluent).  The 
filtrate was concentrated to a yellow oil.  Residual solvent was removed via azeotropic distillation with 





[1,3]dioxolane]-5'-carboxylate (2.89): NaBH4 (46.4 mg, 1.23 mmol) was added to a solution of 2.88 (425.1 
mg, 0.82 mmol) in THF (5 ml).  The reaction was stirred for 30 minutes at rt.  The reaction was quenched 
with saturated NH4Cl solution (5 ml).  The layers were partitioned and the aqueous layer was extracted with 




concentrated via rotary evaporation.  The crude residue was purified via flash chromatography 




benzo[d][1,3]dioxole-7',4''-[1,3]dioxolane]-2,6'(5'H)-dione (2.93): A 1 M aqueous solution of NaOH (6.5 
ml, 6.47 mmol) was added to a solution of 2.81 (1.000 g, 2.16 mmol) in THF (13 ml).  The reaction was 
stirred for 30 minutes, during which heavy precipitation occurred.  The slurry was diluted with water (30 ml) 
and the precipitate was collected by vacuum filtration through a glass filter funnel.  The collected precipitate 
was washed with water (2 x 5 ml), MeOH (2 x 5 ml), and pentane (2 x 5 ml).  Residual solvent was removed 




benzo[d][1,3]dioxole-7',4''-[1,3]dioxolane]-2,6'(5'H)-dione (2.94): A solution of SmI2 (0.1 M, 8.6 ml, 0.86 
mmol) in anhydrous THF was rapidly added via syringe to a solution of 2.93 (145.6 mg, 0.41 mmol) in 
anhydrous THF (2 ml) at 0 °C under N2.  The reaction was stirred for 45 sec then quenched with AcOH 
(0.23 ml, 4.10 mmol) followed immediately by saturated Na2S2O3 (5 ml).  The mixture was diluted with water 
(1 ml) and the layers were portioned.  The aqueous layer was extracted with EtOAc (2 x 2 ml).  The 
combined extracts were washed with brine (3 ml), dried over Na2SO4, filtered, and concentrated via rotary 
evaporation.  The crude residue was purified via flash chromatography to afford 2.94 (110.1 mg, 75%) as 







dione (2.112): TBSCl (356.5 mg, 2.37 mmol) was added to a mixture of 2.94 (384.2 mg, 1.08 mmol) and 
imidazole (219.6 mg, 3.23 mmol) in CH2Cl2 (6.0 ml).  The reaction was stirred at rt for 15 h.  The reaction 
mixture was diluted with hexanes (18 ml).  The mixture was stirred for 10 min. then filtered through a plug 
of Celite®.  The Celite® plug was washed with Et2O (2 x 3 ml) and the combined filtrate was concentrated 
via rotary evaporation to afford a mixture of 2.112 and TBSOH.  TBSOH was removed under vacuum at 80 
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